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1 
5,084,572 
SALTS OF 3-AZABICYCLO [3.3.l]NONANES AS 
A1''TIARRHYTHMIC AGE1''TS, AND 
PRECURSORS THEREOF 
2 
ties. Certain sulfur-substituted, as well as selenium-sub-
stituted examples, have been reported as accessible via a 
Mannich reaction or a modified Mannich reaction. In 
U.S. Pat. No. 4,581,361 and U.S. Pat. No. 4,778,892, for 
BACKGROUND OF THE INVENTION 
5 example, such materials are disclosed and claimed as 
antiarrhythmic agents. 
1. Field of the Invention SUMMARY OF THE INVENTION 
This invention relates to antiarrhythmic composi-
tions. Specifically, this invention relates to certain de-
rivatives of 3-azabicyclo[3.3. l]nonanes. 
The present invention involves novel derivatives of 
10 3-azabicyclo[3.3.l]nonanes having the basic formula: 
/ \ \ 
y z N-R HX 
\ I I Q X = CI04, Br, Cl, HS04, 
citrate, fumarate 
y z R Q Number 
PhC(O)N CH2 (H3C)2CH CH2 (I) 
4-ClC6ff4C(O)N CH2 (H3C)2CH CH2 (2) 
3,4-(H3C0)2C6ff3C(O)N CH2 (H3C)2CH CH2 (3) 
3,4,5-(H3COhC6H2C(O)N CH2 (H3C)2CH CH2 (4) 
PhCH2N CH2 (H3C)2CH CH2 (5) 
4-CIC6ff4CH2N CH2 (H3C)2CH CH2 (6) 











2. Description of the Prior Art 
3-Azabicyclo[3.3. l]nonanes with heteroatoms such as 
N, S, and O at the 7-position are known and docu-
mented in the chemical literature. A review in Chemical 
Reviews, Volume 81, No. 2, pages 149-174 (1981), enti- 45 
tied "Chemistry of 3-Azabicyclo[3.3. l]nonanes" by R. 
Jeyaraman and S. Avila, covers the synthesis, reactions 
and stereochemistry of the title compounds. The review 
acknowledges the close resemblance of 3-azabicy-
clo[3.3. l]nonanes (3-ABN) to aza- and diazaadaman- 50 
tanes in conformation and stereochemistry, and this has 
caused progress in the chemistry of the title compounds. 
The review further acknowledges that 3-ABN systems 
can be obtained by a Mannich, or modified Mannich, 
reaction involving a condensation of ketones or aide- 55 
hydes with a primary amine under relatively mild con-
ditions. Thus, the availability of a variety of ketones or 
aldehydes has prompted studies on 3-ABNs. 
According to the chemical literature, a few deriva-
tives of 3-ABN have exhibited useful biological proper- 60 
ties. Potent analgesic and antitusive characteristics as 
well as antagonism to analgesic effects and to narcotic 
action have been observed, depending upon the groups 
attached to the basic structure. In addition, some exam-
ples have displayed sedative action as well as antipy- 65 
retie and hypoglycemic activity. Simple 3-ABN has 
been reported to be effective against influenza infection. 
Some derivatives have recorded antiarrhythmic proper-
CH2 (H3C)2CH CH2 (8) 
CH2 3-I-C6ff4CH2 CH2 (9) 
CH2 PhCH2 CH2 (JO) 
C(OCH3)2 PhCH2 CH2 (11) 
C(OCH3)2 PhCH2 CH2 (12) 
CH2 PhCH2 CH2 (13) 
s PhCH2 CH2 (14) 
I ) C 
\ 
s 
CH2 PhC(O) CH2 (15) 
C(OCH3)2 PhCH2 CH2 (16) 
CH2 PhCH2 c=o (17) 
The present invention also provides for novel inter-
mediates of the class of 3-azabicyclo[3.3. l]nonan-9-ones 































The invention further provides additional 3-azabicy-



















































Wherein the 3-position in general structures (39-41) is 
nitrogen [as specifically in (1-38)], the 7-position in-
cludes nitrogen [as specifically in (1-7), (12), (17), (19), 
(21-24), and (30-37)], sulfur [as specifically in (8-11), 
5 (15), (16), (18) and (25-29)], and carbon [as specifically 
in (13), (14), (20), and (38)]. With nitrogen in the 3- or 
7-position, a N-C bond is always present except for 
(28) and (31) which have N-H bonds and (36) which 
has an N-S bond. The 9-position can be preferably 
IO unsubstituted [as specifically in (1)-(10), (13), (15), (17), 
and (27)-(38)], 9-one [as specifically in (18)-(26)], 9,9-
dimethoxy [as specifically in (11), (12), and (16)], or a 
1,3-dithiolane [as specifically in (14) and (38)]. The al-
kylated nitrogen atom at the 3-position [as specifically 
15 in (1)-(16)] and their corresponding tertiary amine acid 
salts [hydroperchlorate, HCl, HBr, H2S04, citrate, and 
fumarate] are included along with a system containing 
an alkylated nitrogen at the 7-position as in (17) and the 
corresponding salts. 
20 These compounds are the active ingredients for po-
tential drugs and/or intermediates for the active ingre-
dients of potential drugs to use in the treatment of disor-
ders of the heart. They exhibit good activity in animal 
Specifically, the invention relates to the above salts 
(1)-(17) of certain 3-azabicyclo[3.3.l]nonanes and pre- 25 
cursors (18)-(38) as used in controlling antiarrhythmic 
processes. Thus, it is the object of the present invention 
models and as such are viable candidates to control 
life-threatening arrhythmias found in humans who ex-
perience heart attacks or major infarctions of the heart. 
Typically, the 9-one systems shown by the general 
to provide novel compositions that display biological 
activity. Fulfillment of this object and the presence and 
fulfillment of other objects will be apparent upon com- 30 
plete reading of the specifications and claims. 
formula (39) [as specifically in (18)-(26)] are synthesized 
by the reaction of a tetrahydro-4-heteracyclohexanone 
in the presence of an aldehyde and amine or ammonium 
salt in accordance with a Mannich or Mannich type 
DESCRIPTION OF THE PREFERRED 
EMBODIMENTS 
The chemical compositions according to the pre- 35 
ferred embodiments of this invention are heteronuclear 
ring organic compounds based on the 3-azabicy-
clo[3.3. l]nonane structures as follows: 
reaction. For example, and as illustrated in the follow-
ing reaction scheme A, l-isopropyl-4-piperidinone (42) 
[or l-benzyl-4-piperidinone (43) or 4-thianone (44)] was 
allowed to react with benzylamine, 4-chlorobenzyla-
mine, 3,4-dimethoxybenzylamine, 3,4,5-trimethoxyben-
zylamine, and the like with paraformaldehyde in the 
presence of acetic acid/methanol to produce the 3-
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N-R 
c39) 40 amples are (18), (19), and (21)-(24)]. The ketone (39) is 
then reduced with hydrazine hydrate in triethylene 
glycol/potassium hydroxide media to give members of 
(40) which could be reacted with perchloric acid, hy-
drochloric acid, hydrobromic acid, sulfuric acid, citric 
45 acid, or fumaric acid in benzene, ether, and/or isopro-
(40) pyl alcohol to yield the corresponding hydroperchlo-
rate, hydrochloride, hydrosulfate, citrate, or fumarate 
derivative (41). Related examples where Y is benzyl or 
sulfur follow similarly. Thus the method is applicable to 
50 obtain members of ( 18)-(26), with the exception of (20) 
which was prepared from 
REACTION SCHEME A 
+ RNH2/H2C=O/HOAc/H3COH ~(39) 
H2NNH2/K.OH 
TEG/H2O 
Y = (H3C)2CHN, PHCH2N, S L HCIO,4/solvent 
(42) (43) (44) (41) "'=-,;;;:----- (40) 
5 4 (41) the enamine in scheme B starting from (43). The co-\ \ reactant with (43) to give (20) is made by 
92 N-R HX 65 
I I Q REACTION SCHEME B 
2 




REACTION SCHEME B 
6 
produces salts (41) illustrated by (1)-(4) as representa-
tive examples. 
Ketal formation from members of (39), using metha-
nol or 1,2-ethanedithiol, under standard conditions, 
5 produced members of (40), such as illustrated with (38) 
as a representative example, or, after treatment with 
perchloric acid, HCl, HBr, H2SO4, citric or fumaric 
acid, produced members of (41) such as illustrated with 
(11), (12), (14), and (16) as representative examples. 
EtJN 10 Since oxidation products are viable candidates as 
1-H-
3
-'c_c_N_(20) potential metabolites from use of these compounds in 
animals, including humans, oxidation of specific sites 
was performed. As an example, oxidation of (37) illus-





15 nitrogen when treated with RuO2xH2O/NalO4 in a 
water/carbon tetrachloride mixture to produce lactam 
(17). Moreover, oxidation of sulfur to give members of 
(41), with sulfoxides (10) and (16) as representative 
examples, can lead to potential metabolites. Salt forma-
20 tion is again effected by the method outlined previously 
for members of ( 41 ). 
(45) (EtO2C)2C(CH2OH)i 
treatment of ester (45) with hydrobromic acid to give 25 
acid (46) under standard conditions. Esterification of 
(46) under the usual conditions produced dibromide 
(47) which was condensed with the enamine in the 
presence of triethylamine in acetortitrile to yield ketone 
(20) under the usual conditions. 30 
Reduction of the ketones in scheme A, including 
ketone (20), via Wolff-Kishner conditions, as illustrated 
with hydrazine/KOH in triethylene glycol, leads to 
amines of general formula (40) [specifically (27), (30), 
and (37) are representative examples]. Addition of per- 35 
chloric acid [or HCl, HBr, H2SO4, citric acid, or fu-
maric acid] in benzene or isopropyl alcohol gives mem-
bers of general formula (41) [(5)-(9), and (13) are re-
spresentative examples]. 
In reaction scheme C, members of (40) [representa- 40 
tive examples are (28), (29), (31), and (32)-(36)] were 
obtained as outlined. Specific members of the family of 
(40) with an N-H bond [note these examples are repre-
sentative starting materials for the amide systems], 
namely (28) and 
REACTION SCHEME C 
HCO2Nl4/H3COH 
/ 10% Pd/C/heat ) (40) [R = HJ 
Y~NCH,N 
EXAMPLE I 
7-Benzyl-3-thia-7-azabicyclo[3.3. l]nonan-9-one (18) 
Ketone (18) was prepared by the method in U.S. Pat. 
No. 4,581,361. 
EXAMPLE II 
7-Benzyl-3-thia-7-azabicyclo[3.3. l]nonane (27) 
This amine (27) was prepared from ketone (18) by the 
method of Bailey, III, et. al. J. Med. Chem., vol. 27(6) 




This amine salt was prepared from amine (27) by the 
method of Bailey, III, et. al. J. Med. Chem., vol. 27(6) 
pp. 758-767 (1984). 
EXAMPLE IV 
3-Thia-7-azabicyclo[3.3. l]nonane (28) 
A 50-mL, three-necked, round-bottomed flask was 
'-.._ I. HCO2Nl4/H3COH 
10% Pd/C/heat 
2. ArC(O)CI or ArSO2CI 
) (40) [R = ArC(O) or ArSO2) t HCIO4/solvent 
(41) 
(31) as representative examples, are isolable directly 
from the reaction mixture after workup. Direct aroyla- 60 
tion or sulfonation of these types of intermediates ( 40) in 
a two-phase system under modified Schotten-Baumann 
conditions, or phase transfer conditions, leads to amide 
members of(39) [(29), (32)-(35), and (36) are representa-
tive examples]. Treatment of these latter amide mem- 65 
bers of (40), such as (32)-(35) and related systems, with 
perchloric acid, HCI, HBr, H2SO4, citric acid, or fu-
maric acid in benzene, ether, and/or isopropyl alcohol 
equipped with a magnetic stirrer, a heating mantle, a 
standard condenser with a N2 inlet and two glass stop-
pers. In one portion, anhydrous HCO2NH4(1.l lg, 17.1 
mmol) was added under N2 to a mixture of the amine 
(27, 0.90 g, 3.86 mmol) and 10% Pd/C (0.90 g) in anhy-
drous CH3OH (25 mL). With stirring, the mixture was 
brought to reflux for 30 min, filtered through a Celite 
pad on a fritted funnel (which was washed thoroughly 
with CH2Clz), and then concentrated to give a gummy 




solved in CH2Cl2 ( ~ 15 mL), and the suspension was 
filtered to remove any unreacted ammonium formate. 
The filtrate was then concentrated to near saturation 
and placed in a diffusion chamber of ether overnight. 
Crude amine (28) became an oil; however, the mother 5 
liquor, containing predominantly starting material, 
could be decanted. Chromatography of the oil em-
ployed a gradient elution of CH3OH/CH2Cl2 (300 mL 
wise to the mixture over 30 min, followed by stirring at 
reflux for an additional 18.5 h. Concentration of the 
solution gave an oil which was redissolved in H2O (100 
mL). An ether extract (100 mL) of this acidic solution 
was discarded. Basicification (pH~ 13) of the water 
layer was achieved by the addition of 10% NaOH, 
resulting in the formation of a milky suspension which 
was extracted (ether, 4X60 mL). Combined extracts 
were dried (Na2SO4, 1 h), filtered, and concentrated to 
a viscous red oil, which, when distilled (175°-185° 
c.110-s mm Hg), afforded a light yellow oil (15.6 g, 
57.2%) that solidified when refrigerated at -10• C.; mp 
46° -4 7 .5° C. This solid could be recrystallized (pentane) 
to give an analytical sample of ketone (21); mp 49°-50° 
C. IR (KBr) cm-I 3095, 3070, 3035 (Ar-H), 2975, 
2900, 2820 (C-H), 1745 (C==O), 1605, 1495 (C=C), 
740, 700 (C-H out of plane, mono); 1H NMR (DCCl3) 
of 10% CH3OH/CH2Cli, 50 mL of 20% 
CH3OH/CH2Cl2, 100 mL of 50% CH3OH/CH2Cli, 10 
and 100 mL of CH3OH) on silica gel (35 g, 1.5 cm X 62 
cm) and afforded 0.32 g (56.9%) of amine (28) 
(Rp0.11, 10% CH3OH/CH2Ch) as a light, gummy 
solid which was used without further purification. 1H 
NMR (DCCl3) ol.84, 2.04 [two bd, 2H, H(9)], 2.31 [bs, 15 
2H(l,5)], 2.80 [bd, 2H, H(2,4)ax, J = 12.3 Hz], 3.20 [bd, 
2H, H(2,4)eq, J=l3.7 Hz], 3.45 [m, 2H, H(6,8)ax], 3.73 
[bd, 2H, H(6,8)eq, J = 13.2 Hz], 7.59 (bs, lH, N-H); 13C 
NMR (DCC13) ppm 24.88 [d, C(l,5)], 29.79 [t, C(9)], o_l.02 (d, 6 H, CH3), 2.58 [bs, 2 H, H(l,5)], 2.87 fm, 5 H, 
32.17 [t, C(2,4)], 47.8 [t, C(6,8)]. 
20 
nng protons and CH(CH3)2], 3.03 (dd, 4 H, nng pro-
EXAMPLE V 
7-Benzoyl-3-thia-7-azabicyclo[3.3. l]nonane (29) 
A 10-mL, two-necked, round-bottomed flask was 
equipped with a magnetic stirrer, an ice bath, a standard 25 
condenser with a N2 inlet, and a glass stopper. To a 
chilled (5° C.) solution of NaOH pellets (0.1 g, 2.38 
mmol) in H2O. (1.7 mL) was added a solution of the 
amine (28, 0.17 g, 1.19 mmol) in CH2Cl2 (1 mL). This 
" was followed by the dropwise addition of a solution of 30 
benzoyl chloride (0.2 g, 1.43 mmol) over ~ 5 min. After 
tons), 3.53 (s, 2 H, ArCH2), 7.30 (m, 5 H, Ar-H); 13C 
NMR (DCCI)) ppm 18.25 (CH3), 46.93 [C(l,5)], 53.41 
[CH(CH3)2], 53.71 [C(2,4)], 58.07 [C(6,8)], 61.25 
(ArCH2), 127.09, 128.25, 128.69, 138.67 (Ar-C), 215.20 
(C==O); 15N NMR (DCCl3) ppm 39.25 [N(7)], 40.80 
[N(3)]. Anal. Calcd. for C17H24N2O: C, 74.96; H, 8.88; 
N, 10.28. Found: C, 75.18; H, 8.61; N, 10.24. 
EXAMPLE VII 
7-Benzyl-3-isopropyl-3, 7-diazabicyclo[3.3. I ]nonane 
(30) 
stirring for 30 min at o• -5° C., 30 min at RT, and then 15 To a mixture of KOH pellets (85%, 11.62 g, 176 
min over a steam bath, the mixture was diluted with mmol) and the ketone (21) (6.0 g, 22 mmol) in triethyl-
H2O (15 mL), and the mixture was extracted (CH2Ch, ene glycol (100 mL) was added hydrazine (95%, 2.97 g, 
3X 15 mL). Combining the extracts, drying (Na2SO4, 35 88 mmol) in one portion in a 200-mL, jacketed flask 
overnight), filtering, and concentrating the solution equipped with a magnetic stirrer, a heating mantle, a 
gave a viscous yellow·oil. Chromatography of the oil on standard condenser, a lower take-off condenser with a 
alumina (38 g, 2.4 cm X 17 cm) employed ethyl acetate N2 inlet, and two glass stoppers. A heating temperature 
as eluant and afforded amide (29) (Rp0.47) as white of 200° -210• C. for 4 h under N2 was produced by boil-
crystals (157 mg, 53.3%); mp 95°-96° C. IR (KBr) 40 ing tetralin (bp 207° C.) in the jacket. Cooling of the 
cm-I 3065, 3045 (Ar C-H), 3000, 2985, 2940, 2910, solution to RT was followed by the addition of chilled 
2855, 2835 (C-H), 1635 (C==O), 745, no (C-H out of water (125 mL). Combined extracts (ether, 4X50 mL) 
plane, mono); 1H NMR (DCCl3) ol.78-l.93 [m, 3H, of the suspension were washed with 10% NaOH (50 
H(9) and H(l)], 2.15 [bs, lH, H(5)], 2-39 [d, lH, H(4)ax, mL) and saturated NaCl (50 mL), dried (Na2SO4, 1 h), 
J = 13.9 Hz], 2-77 [d, lH, H(6)ax, J = 12·3 Hz], 3· 12- 3·21 45 filtered, and concentrated (rotary evaporator then vac-
[m, 3H, H(4)eq and H(6)eq], 3.4l [d, lH, H(2)ax, J = 12·8 uum pump, overnight, RT /0.2 mm Hg) to a yellow oil 
Hz], 3.89 [d, lH, H(2)eq, J = 13.4 Hz], 4.98 [d, lH, (S 53 97 3n1) A I · f h 1· h d · H(8)eq, J=l3.I Hz], 7.38-7.44 [m, SH, Ar-HJ; 13C . g, . ,o. nays1so t ever_ys1g tcru eamme 
NMR (DCClJ) ppm 26.53 [C(l)], 26.87 [C(5)], 31,73 (30) sho~ed no carbo~yl stretch m the_IR spectrum, 
[C(2)], 31.78 [C(9)], 32.34 [C(4)], 46.07 [C(8)], 52_12 50 and thus 1t was used without further punficat1on. 
[C(6)], 126.46, 128.41, 128.83, 137.35 (Ar-C), 170.38 EXAMPLE VIII 
[C==O]. Anal. Calcd. for C14H17NOS: C, 67.98; H, 6.93. 
Found: C, 68.01; H, 7.07. 
EXAMPLE VI 
7-Benzy 1-3-isopropyl-3, 7-diazabicyclo[3.3.1 ]nonane 
Hydroperchlorate (5) 
55 A 125-mL Erlenmeyer flask was equipped with a 
7-Benzyl-3-isopropyl-3, 7-diazabicyclo[3.3. l]nonan-9- magnetic stirrer and an ice bath. To a stirred, chilled (5° 
one(21) C.) solution of the amine (30, 0.84 g, 3.25 mmol) in dry 
A 500-mL, three-necked, round-bottomed flask was ether (50 mL) was added dropwise a solution ofHClO4 
equipped with a magnetic stirrer, a heating mantle, a (60%, 1.08 g, 6.50 mmol) in isopropyl alcohol (3 mL) 
250-mL addition funnel, a standard condenser with a 60 over 20 min. After the mixture was stirred an additional 
N2 inlet and a glass stopper. A mixture of benzylamine hour, a white powdery material was filtered, and then 
(10.71 g, 100 mmol), HCl (37%, 9.86 g, 100 mmol), dissolved in CH3OH. Decolorizing with Norit, filter-
glacial acetic acid (3.0 g, 50 mmol) and paraforrnalde- ing, and concentrating the solution gave a solid that was 
hyde (6.31 g, 210 mmol) in deoxygenated (N2 bubbled in recrystallized (CH3OH) to give 0.65 g (49.4%) of salt 
for 1 h) CH3OH (100 mL) was stirred at reflux for 15 65 (5); mp 152.0°-152.5° C. IR (KBr) cm- 1 3050, 3030 (Ar 
min under N2. A solution of 1-isopropyl-4-piperidinone C-H), 2970, 2940, 2910, 2810 (C-H), 1090 (Cl-O); 
(42, 14.12 g, 100 mmol) and glacial acetic acid (6.0 g, IH NMR (DMSO-d6) ol.18 (d, 6 H, CH3), 1.62 [d, 1 H, 




[bs, 2 H, H(l,5)], 2.47 [d, 2 H, H(6,8)ax, 1 = 11.4 Hz], 3.11 
[m, 4 H, H(2,4)ax and H(6,8)eq], 3.32 [d, 2 H, H(2,4)eq, 
1 = 11.8 Hz], 3.47 [h, 1 H, CH(CH3)2], 3.52 (s, 2 H, 
ArCH2), 7.30-7.46 (m, 5 H, Ar-H); 13C NMR 
(DMSO·d6) ppm 16.11 (q, CH3), 27.24 [d, C(l,5)], 29.67 5 
[t, C(9)], 52.85 [t, C(2,4], 56.00 [d, CH(CH3)2], 56.85 [t, 
C(6,8)1, 61.15 (t, ArCH2), 127.65, 128.35, 129.38, 136.35 
(Ar-C); ISN NMR (DMSO-d6) ppm 50.90 [N(7)], 
60.47 [N(3)]. Anal. Calcd. for C17H27ClN2O4: C, 56.90; 
H, 7.58; N, 7.81. Found: C, 56.70; H, 7.45; N, 7.84. 10 
EXAMPLE IX 
3-Isopropyl-3,7-diazabicyclo[3.3.l]nonane (31) 
1 = 11.0 Hz], 2.62 [m, 1 H, CH(CH3)2, 1 =6.5 Hz], 2.72 
[d, 1 H, H(6)eq, 1 = 10.6 Hz], 3.04-3.07 [m, 2 H, H(2)ax 
and H(4)eq], 3.30 [d, 1 H, H(8)ax, 1 = 13.2 Hz], 3.74 [d, 1 
H, H(8)eq, 1 = 12.8 Hz], 4.77 [d, 1 H, H(2)eq, 1 = 13.9 Hz], 
7.28-7.41 (m, 5 H, Ar-H); 13C NMR (DCCl3) ppm 
16.30 (CH3), 19.33 (CH3), 29.06 [C(l)], 29.76 [C(5)], 
32.29 [C(9)], 46.55 [C(2)], 52.19 [C(4)], 52.62 [C(8)], 
54.34 [CH(CH3)2], 54.75 [C(6)], 126.75, 128.24, 128.67, 
137.75 (Ar-C), 170.09 (C=O). 
EXAMPLE XI 
3-Benzoyl-7-isopropy 1-3, 7-diazabicyclo[3.3. l )nonane 
Hydroperchlorate (1) 
A 200-mL, three-necked, round-bottomed flask was . . 
equipped with a magnetic stirrer, a heating mantle, a 15 A 25_0-m~ Erlenmey~r flask was equ11:ped w.1th a 
condenser with a N2 inlet, and two glass stoppers. To a m_agnet1c st~er and an l7e bath. To a chilled (5 C), 
stirred mixture of amine (30) (5.53 g, 21.4 mmol) and stirred solution of the amide (3~, 1.52 g, 5.58 mmol) m 
10% Pd/C (0.64 g 30 mg/mmol of amine) in cH3oH ether (60 mL) was added dropw1se HClO4 (60%, 1.17 g, 
(80 mL) was added anhydrous HCO2NR4 (3.37 g, 53.5 6.9~ mm~l) ov~r .10 min. Filtrat!on gave salt (1) as a 
mmol) in one portion. Stirring the mixture at reflux 20 w~ute s?hd which was washed with dry ether (50 mL), 
under N2 for 30 min, cooling the new mixture to RT, stirred m hot CH3OH (30 mL), cooled to -10• C. over-
and filtering through a celite pad was followed by con- • night, filtered, and dried (vacuum pump, 61° C./0.2 mm 
centration of the resulting solution to give a viscous oil. Hg, overnight) to afford 1.90 g (91.3%) of pure salt (l); 
The oil was then dissolved in H2O (80 mL) and the pH mp 226°-227° C. (dee): IR (KBr) cm-
1 3150 (N-H), 
was adjusted to ~ 12 by the addition of 10% NaOH. 25 2990, 2960, 2935, 2920, 2885 (C-H), 1635 (C=O), 1100 
Combined extracts (CH2Cli, 4X40 mL) of the aqueous (Cl-O), 740, 710 (C-H out of plane, mono); 1H NMR 
solution were dried, filtered, and concentrated (rotary [(D3C)2C=0)61.55 (d, 6 H, CH3, 1 =6.6 Hz), 1.97 [bd, 
evaporator then vacuum pump, 10 min, RT/0.2 mm 1 H, H(9), 1 = 13.0 Hz], 2.18 [bd, 1 H, H(9), 1 = 13.2 Hz], 
Hg) to give amine (31) as a light oil (3.35 g, 93.0%) 2.51 [bs, 2 H, H(l,5)], 3.30 [bd, 2 H, H(2,4)ax, 1=13.2 
which was used without further purification. IR (film) 30 Hz], 3.65 [m, 2 H, H(6,8)ax], 3.83 [h, 1 H, -CH(CH3)2, 
cm- 1 3315 (N-H), 2965, 2900, 2850, 2790, 2760, 2725 1=6.8 Hz], 3.94 [bd, 2 H, H(2,4)eq, 1=12.3 Hz], 4.23 
(C-H); 1H NMR (DCCIJ) 61.01 (d, 6 H, CH3, 1=6.7 [bd, 2 H, H(6,8)eq, 1=13.2 Hz], 7.45-7.50 (m, 5 H, 
Hz), 1.60-1.67 [m, 3 H, H(l,5) and H(9)), 1.79-1.84 [m, Ar-H), 7.85 (bs, 1 H, N-H); 13C NMR (DMSO-d6, 
1 H, H(9)], 2.53-2.59 [m, 3 H, ring protons and so• C.) ppm 16.34 (CH3), 26.69 [C(l,5)], 27.62 [C(9)), 
CH(CH3)2], 2.90-3.06 [m, 6 H, ring protons], 3.56 (bs, 1 35 48.80 [C(2,4)], 52.31 [C(6,8)], 59.91 [CH(CH3)2], 127.05, 
H, N-H); 13C NMR (DCCl3) ppm 18.12 (CH3), 30.04 128.30, 129.40, 136.40 (Ar-C), 172.86 (C=O). Anal. 
[C(l,5)], 33.62 [C(9)], 52.86 [C(6,8)], 54.59 [CH(CH3)2], Calcd. for C17H2sClN2Os: C, 54.76; H, 6.76. Found: C, 
54.65 [C(2,4)]. 54.43; H, 6.78. 
EXAMPLEX 
3-Benzoyl-7-isopropyl-3, 7-diazabicyclo[3.3. l]nonane 
(32) 
40 EXAMPLE XII 
3-(3' ,4' -Dimethoxybenzyl)-7-isopropyl-3, 7-diazabicy-
clo[3.3. l]nonan-9-one (23) 
~ three-~ecked, 50-~L, _round•b?ttomed flask was A 200-mL, three-necked, round-bottomed flask was 
equipped wit? a mag~et1c stirrer, an ice bath, a standard equipped with a magnetic stirrer a heating mantle a 
condenser with a N2 mlet, and two glass stoppers. To a 45 . . ' . .' 
1 t. f 10n1 N OH (8 94 22 3 l) dd d standard condenser with a N2 mlet, a 50-mL add1t1on so u 10n o ·/o a . g, . mmo was a e f I d I A • · · 3 4 the amine (31, 1.14 g, 6.77 mmol) in CH2Cli (15 mL) in ~nne' an a g ass ~topper. 1D1Xture contammg , . 
one portion. Dropwise addition of a solution ofbenzoyl dtmethoxybenzylamme (8-36 g, 50 mmol), paraformal-
chloride (1.05 g, 7.45 mmol) in cH2cii (5 mL) to the dehyde ~3:15 ~• 105 mm<:>l! and CH3?H (3~ m~) was 
mixture over 15 min under N2 was followed by stirring 50 made ac1d1c wit~ t_he add1t1~n of glacial acetic acid (3:° 
an additional 2.75 hat RT. After the addition of H2O g, 50 mmol). St1mng the n_uxture_ ~nder N~ for 20 mm 
(30 mL), the organic layer was separated. Additional "".as f?l!owed by the dropw1se add1t1on of l-1so?ropyl-~-
extracts (CH2c12, 3 x 25 mL) were combined with the p1I:Cndmone (42, 7.06. g, 50 mmol) and glacial acetic 
initial organic layer, dried (Na2SO4, 1 h), filtered, and ac1?. (3.0 g, 50 ~mol) m CH3O~ (25 mL) over ~-~5 h. 
concentrated (aspirator followed by vacuum pump, 1 h, 55 Bmlmg o_f the m1x~ure was contmuous for an ~dd1t1onal 
RT /0.2 mm Hg) to give an orange oil. Chromatography 23 h. This new mixture was evaporated to give a red 
of the oil was performed over neutral alumina (200 g, viscous oil. After dissolving the oil in H2O (100 mL), 
2.1 cm X 33 cm) with ethyl acetate as eluant. Fractions the solution was extracted (ether, 2 X 100 mL), the latter 
(Rp0.70) were combined and concentrated (rotary being discarded. Chilling (ice water bath) of the water 
evaporator then vacuum pump, overnight, RT /0.2 mm 60 layer below 10• C., followed by basification (pH~ 12) 
Hg) to yield 1.52 g (82.4%) of the amide (32) as an oil with KOH pellets (6.6 g, 100 mmol), produced an 
which was used without further purification. IR (film) orange suspension which was extracted (CH2Ch, 4 X 80 
cm- I 3085, 3065, 3035 (Ar C-H), 2970, 2925, 2865, mL). Combined extracts were dried (Na2SO4, over-
2805, 2780, 2750 (C-H), 1635 (C=O), 730, 710 (C-H night), filtered, and concentrated to give a crude oil. 
out of plane, mono); IH NMR (DCCl3) 60.96 (d, 3 H, 65 This oil was digested in 250 mL of Skelly B (bp 60°-68° 
CH3, 1 = 6.4 Hz), 1.07 (d, 3 H, CH3, 1 = 6.6 Hz), C.) for 0.5 h and the supernatant was decanted. Evap-
1.65-1. 78, [m, 3 H, H(5) and H(9)], 1.97 [bs, 1 H, H(l)], oration of the solvent gave an oil which, when distilled 




Adding Skelly B induced crystallization to give 4.32 g mmol), and CH3OH (35 mL) was brought to gentle 
(26%) of off white ketone (23); mp 79.5°-80.5° C. IR reflux with stirring under N2 for 15 min. To the mixture 
(KBr) cm- 1 3095, 3015 (Ar-H), 2980, 2955, 2920, was added dropwise a solution of l-isopropyl-4-
2855, 2810 (C-H), 1745 (C==O), 1620, 1605 (C=C); 1H piperidinone (42, 7.06 g, 50 mmol) and glacial acetic 
NMR (DCCl3) 61.03 (d, 6 H, CH3, J =6.6 Hz), 2.59 [bs, 5 acid (3.0 g, 50 mmol) in CH3OH (25 mL) over 1 h. 
2 H, H(l,5)], 2.81-2.90 [m, 5 H, ring protons and Boiling of the mixture was continued for an additional 
CH(CH3)2], 2.98 (dd, 2 H, ring protons, J = 10-7 Hz, 24 h. After concentrating to a viscous red oil, the reac-
1: =3.2 Hz), 3.08 (dd, 2 H, ring protons, J = 10-7 Hz, tion mixture was then diluted with H2O (100 mL) and 
J =2.99 Hz), 3.47 (s, 2 H, ArCH2), 3.87 (s, 3 H, OCH3), t t d ( th 3 X 100 L) th I tt b · d" d d 
3.88 (s, 3 H, OCH3), 6.80-6.92 (m, 3 H, Ar-H); !3C 10 ex :a~ e ~ ~r, m , e a er eing iscar e . 
NMR (DCCIJ) ppm 18.17 (CH3), 46.85 [C(l,5)], 53_40 Chilling \via ice water bath) of th~ aqu~ous layer to 
[CH(CH3)2], 53.86 [C(2,4)], 55.76, 55.86 (OCH3), 58.0l ~low 10 C. was followed by bas1ficat1on (pH--:-13) 
[C(6,8)], 60.93 (ArCHz), 110.60, 111.46, 120.68 131.30, with KOH pellets (85%, 6.6 g, 100 mmol). Combined 
148.04 148.90 (Ar-C) 215.27 (C==O)· 15N NMR extracts (ether, 3X60 mL) were dried (Na2SO4, 4 h), 
(Dcci3) ppm 39.66 [N(7)], 40.93 [N(3)]. 'Anal. Calcd. 15 filtered, and concentrated to give a viscous red oil. This 
for c 19H28N2o3: C, 68.65; H, 8.49. Found: C, 68.70; H, oil was digested in pentane (100 mL) for 20 min and the 
8.53. supernatant was decanted and concentrated. Distilla-
EXAMPLE XIII 
tion of the resulting oil (195°-205° C./10-5 mm Hg) 
gave 5.25 g of a yellow oil which solidified upon stand-
7-(3',4'-Dimethoxybenzyl)-3-isopropyl-3, 7-diazabicy- 20 ing. Recrystallization (pentane) of the solid gave 3.46 g 
clo[3.3.l]nonane Hydroperchlorate (7) (22.6%) of white crystalline (22); mp 68°-69° C. IR 
To a mixture of KOH pellets (85%, 2.38 g, 36 mmol) (KBr) cm- 13030 (Ar C-H), 2955, 2880, 2800 (C-H), 
and the ketone (23, 1.0 g, 3 mmol) in triethylene glycol 1730 (C==O), 800 (C-H out of plane, para); IH NMR 
(25 mL) was added hydrazine (95%, 1.01 g, 30 mmol) in (DCCl3) 61.03 (d, 6 H, CH3, J = 6.3 Hz), 2.58 [bs, 2 H, 
one portion in a 70-mL, jacketed flask equipped with a 25 H(l,5)], 2.80-3.05 [m, 9 H, ring protons and CH(CH3)2], 
magnetic stirrer, a heating mantle, a standard con- 7.27 (s, 4 H, Ar-H); 13C NMR (DCCl3) ppm 18.25 
denser, a lower take-off condenser and two glass stop- (CH3), 46.85 [C(l,5)], 53.40 [CH(CH3)2], 53.76 [C(2,4)], 
pers. A heating temperature of 150°-160° C. for 3.5 h 57.92 [C(6,8)], 60.48 (ArCH2), 128.40, 129.95, 132.74, 
was achieved by using tetralin (bp 207° C.) in the jacket. 137.21 (Ar-C), 215.04 (C==O); 15N NMR (DCCl3) 
After cooling to RT, the solution was diluted with cold 30 ppm 39.18 [N(3)], 40.31 [N(7)]. Anal. Calcd. for 
H2O (50 mL) and extracted with ether (3 X 40 mL). C17H23CIN2O: C, 66.55; H, 7.56. Found: 66.47; H, 7.52. 
Combined extracts were washed with 10% NaOH (50 EXAMPLE XV 
mL) and saturated NaCl (50 mL), dried (Na2SO4, over-
night), filtered, and concentrated to afford a yellow oil 7-(4'-Chlorobenzyl)-3-isopropyl-3,7-diazabicyclo[3.3.1-
(0.78 g). Dissolution of the oil in ether (50 mL) with 35 ]nonane Hydroperchlorate (6) 
magnetic stirring and cooling (5' C., via ice water bath) 
in a 125-mL Erlenmeyer flask (equipped with an exter- To a mixture of KOH pellets (85%, 1.72 g, 26. J 
nal ice bath) was followed by the dropwise addition of mmol) and the ketone <22, l.O g, 3-26 ~mo!) in triethyl-
a solution of HClO4 (60%, 0.51 g, 3.06 mmol) over 10 ene glycol (~O mL) was_ ad~ed hydrazine _(95%, 0.44 g, 
min. Filtering the precipitate, washing the latter with 40 13.~ mmol) _in one port1~n in_ a 150-mL, J_acketed flask 
ether (~50 mL), and then recrystallizing (95% EtOH) equipped with a magnetic stirrer, a heating mant~e, a 
gave 0.79 g (62.9%) of white salt (3); mp 127.5°-128.0' sta~dard condenser, a lower take-off cond_enser with a 
c. (dee). IR (KBr) cm-I 3020 (Ar C-H), 2955, 2930, N2 inlet, and three glass stoppers. A heating tempera-
2840 2815 2790 (C-H) 1610 (C=C) 1090 (Cl-O)· ture of200'-210° C. for 4 h under N2 was produced by 
IH NMR (DMSO-d6) 61'.15 (d, 6 H, CflJ, J =6.7 Hz)'. 45 boiling tetralin (bp 207° C.) in the jacket. Cooling of the 
1.64 [d, 1 H, H(9), J = 12.1 Hz], 1.80 [d, I H, H(9), solution to RT was followed by the addition of chilled 
J = 13.0 Hz], 2.14 [bs, 2 H, H(l,5)], 2.50 [d, 2 H, H(6,8)ax, water (40 mL). Combined extracts of the resulting sus-
J = 10.4 Hz], 3.05-3.14 [m, 4 H, H(6,8)eqand H(2,4)ax], pension (ether, 4X30 mL) were washed with 10% 
3.28 [d, 2 H, H(2,4)eq, J = 11.6 Hz], 3.39 [m, l H, NaOH (30 mL) and saturated NaCl (30 mL), dried 
CH(CH3), J =6.7 Hz], 3.49 (s, 2 H, ArCH2), 3.75, 3.76 50 (Na2SO4, 4 h), filtered and concentrated to a light yel-
(two s, 6 H, OCH3), 6.86-7.08 (m, 3 H, Ar-H); !3C low oil which displayed no carbonyl stretch in the IR 
NMR (DMSO-d6) ppm 16.25 (CH3), 27.23 [C(l,5)], spectrum and was used without further purification. 
29.79 [C(9)], 52.74 [C(2,4)], 55.31, 55.36 (OCH3), 55.78 Dissolution of the oil in ether (60 mL) at ~5° C. (via ice 
[CH(CH3)2], 56.85 [C(6,8)], 60.89 (ArCH2), 111.23, water bath) was followed by the dropwise addition of a 
l 13.01, 122.02, 128.00, 148.38, 148.66 (Ar-C); 15N 55 solution of HClO4 (60%, 0.68 g, 4.08 mmol) in 
NMR (DMSO-d6) ppm 52.22 [N(7)], 59.43 [N(3)]. Anal. (H3C)2CHOH (1 mL) over 5 min. The resulting, precip-
Calcd. for C19H31ClN2O6; C, 54.48; H, 7.46. Found: C, itated solid was filtered and recrystallized (95% EtOH) 
54.76; H, 7.61. to give 0.81 g (63.3%) of white crystals of (6); mp 
EXAMPLE XIV 140°-141° C. IR (KBr) cm-
1 3060, 3020 (Ar C-H), 
60 2970, 2920, 2830 (C-H), 1485 (C=C), 1085 (Cl-O), 
7-(4'-Chlorobenzyl)-3-isopropyl-3,7-diazabicyclo[3.3.1- 790 (C-H out of plane, para); IH NMR (DMSO-d6) 
]nonan-9-one (22) 61.19 (d, 6 H, CH3, 1=6.7 Hz), 1.61 [d, 1 H, H(9), 
A 200-mL, three-necked, round-bottomed flask was 
equipped with a magnetic stirrer, a heating mantle, a 
standard condenser with a N2 inlet, a 50-mL, an addi- 65 
tion funnel and a glass stopper. A mixture of 4-
chlorobenzy lamine (7.08 g, 50 mmol), paraforrnalde-
hyde (3.15 g, 105 mmol), glacial acetic acid (3.0 g, 50 
J = 12. 7 Hz], 1.82 [d, 1 H, H(9), J = 12.2 Hz], 2.14 [bs, 2 
H, H(l,5)], 2.41 [bd, 2 H, H(6,8)ax, J = 11.2 Hz], 3.04 [bd, 
2 H, H(6,8)eq, J = 11.1 Hz], 3.16 [bd, 2 H, H(2,4)ax, 
J=ll.2 Hz], 3.34 [bd, 2 H, H(2,4)eq, J=ll.7 Hz], 
3.44-3.52 [m, 3 H, CH(CH3)2 and ArCH2], 7.44 [s, 4 H, 




[C(l,5)], 29.60 [C(9)], 52.77 [C(2,4)], 56.25 [CH(CH3)2], 
56.75 [C(6,8)], 60.42 (ArCH2), 128.28, 131.27, 132.14, 
135.72 (Ar-C); ISN NMR (DMSO-d5) ppm 50.34 
[N(7)], 60.57 [N(3)]. Anal. Calcd. for C17H20ChN2O4: 
crop of the acid (46) (3.7 g, 9.0%); mp 95'-97' C. IR 
(KBr) cm- 13500-2500(CO2H), 1700 (C=O); IH NMR 
(DCCl3) 63.27 (m, 1 H, CH), 3.79 (m, 4 H, CH2Br), 
10.91 (bs, I H, CO2H); 13C NMR (DCCl3) ppm 29.80 (t, 
C, 51.92; H, 6.66. Found: C, 51.74; H, 6.57. 5 CH2Br), 48.38 (d, CH), 175.30 (s, CO2H). 
EXAMPLE XVI EXAMPLE XVIII 
Ethyl .B,/3'-Dibromoisobutyrate (47) 3-( 4' -Chlorobenzoyl)-7-isopropyl-3, 7-diazabicy-
clo[3.3. l ]nonane (33) 
10 Into a 250-mL, single necked, round-bottomed flask A 25-mL, three-necked, round-bottomed flask was equipped with a soxhlet extractor, standard condenser, 
equipped with a magnetic stirrer, a standard condenser magnetic stirrer and heating mantle were placed the 
with a N2 inlet, a 10-mL addition funnel and two glass 
stoppers. To a mixture of the amine (31, 0.60 g, 3.57 dibromo acid (46, 27 g, 0.11 mo!), benzene (125 mL), 
mmol) in CHiCh (5 mL) and 10% NaOH (3.S8 g, 8_93 absolute ethanol (50 mL) and cone H2SO4 (0.5 mL). 
mmol) was added dropwise a solution of 4-chlorobenz- 15 Into the Soxhlet extractor was placed a thimble contain-
oyl chloride (0.69 g, 3.92 mmol) in cH2Ch (5 mL) over ing anhydrous MgSO4 (20 g). The reaction mixture was 
15 min. Stirring of the mixture was continued for an heated at reflux for 24 h. Solvent was distilled off until 
additional 3 h under Ni. An aqueous mixture, formed about 50 mL remained. The concentrated reaction mix-
upon addition of HiO (30 mL), was extracted (CHiC12, ture was cooled to RT (0.5. ~), and H!O (50 mL) ~as 
4X25 mL). Combined extracts were dried (NaiSO4, 2 20 a~d~d follo-:ved by slow add1t1on ofsohd_NaHCO3 "'.1th 
h), filtered, and concentrated to give a viscous yellow strrnng until the pH was 7. The resultmg suspension 
oil. Chromatography of the oil was performed by add- was transferred to a separatory funnel and the organic 
ing an ether solution of the oil to a neutral alumina layer was separated. The aqueous layer was extracted 
column (69 g, 1.7 cmX30 cm) and then using 60:40 with ether (3X50 mL). The organic layers were com-
hexanes/ethyl acetate as eluant. Fractions (Rp0.41) 25 bined and washed with H2O (50 mL) and saturated 
were saved and concentrated (rotary evaporator then NaCl (50 mL). This was followed by drying (anhydrous 
vacuum pump, overnight, RT/0.2 mm Hg) to give 0.86 MgSO4, 2 h), filtration, and evaporation (rotary evapo-
g (80.4%) of off-white solid (33); mp 97'-98' C. IR rator, aspirator) to yield a pale brown liquid which was 
(KBr) cm-1 3085, 3070 (Ar C-H), 2965, 2935, 2865, distilled under reduced pressure to yield the ester (47.3 
2800, 2770 (C-H), 1630 (C=O); 1H NMR (DCCl3) 30 g, 94.9%), bp 60'-62' C./0.2 mm Hg. IR (film) cm-1 
60.95 (d, 3 H, CH3, J =6.5 Hz), 1.05 (d, 3 H, CH3, J =6.4 1735 (C=O); IH NMR (DCCl3) 61.30 (t, 3 H, CH3), 
Hz), 1.63-1.75 [m, 3 H, H(5) and H(9)], 1.97 [bs, 1 H, 3.20 (m, 1 H, CH), 3.78 (m, 4 H, CH2Br), 4.25 (q, 2 H, 
H(l)], 2.41 [bd, 1 H, H(4)ax, J=l0.6 Hz], 2.50 [bd, 1 H, OCH2); 13C NMR (DCCl3) ppm 14.18 (q, CH3), 30.75 
H(6)ax, J = 11.2 H], 2.59 [heptet, 1 H, CH(CH3)2, J =6.5 (t, CH2Br), 48.52 (d, CH), 61.66 (t, OCH2), 169.32 (s, 





H, H(2)ax and H(4),9], 3.31 [bd, 1 H, H(8)ax, J = 12.8 
Hz], 3.71 [bd, 1 H, H(8),9, 13.1 Hz], 4.77 [bd, 1 H, 
H(2),9, J = 13.2 Hz], 7.27-7.37 (m, 4 H, Ar-H); 13C 
NMR (DCCb) ppm 16.37, 19.35 (CH3), 29.07 [C(l)], 
29.80 [C(5)], 32.29 [C(9)], 46.68 [C(2)], 52.22 [C(4)], 40 
52.56 [C(8)], 54.38 [CH(CH3)2], 54. 79 [C(6)], 128.35, 
128.51, 134.67, 136.11 (Ar-C), 169.03 (C=O). Anal. 
Calcd. for C11H23CIN2O: C, 66.55; H, 7.56. Found: C, 
As the starting point for the preparation of (20), the 
preparation of l-benzyl-4-pyrrolidinyl-1,2,3,6-tetrahy-
dropyridine was required. Into a 250-mL, single-
45 necked, round-bottomed flask equipped with a Dean-
Stark trap, standard condenser, magnetic stirrer, heat-
66.45; H, 7.71. 
EXAMPLE XVII 
J3,J3'-Dibromoisobutyric Acid (46) ing mantle, and a N2 inlet were placed l-benzyl-4-
Into a 500-mL, single necked, round-bottomed flask piperidino~e. (43, 10-2 g, 55 mmol), benzen~ (12~ mL) 
equipped with a heating mantle, a magnetic stirrer, ·a and pyrrobdme (6.0 g, 85 mmol). The resultmg mixture 
Claisen distillation head a standard condenser and a 50 was heated at reflux for 24 h. The Dean-Stark trap was 
receiver were placed diethyl bis(hydroxymethyl)ma- removed ~? a. simple distillation apparatus was in-
lonate (45, 37 g, 0.17 mo!), and hydrobromic acid (48%, stalled. D~st1llat1on of the solvent was compl~ted_ at 
280 mL, 2.5 mol). The resulting homogeneous solution atmosphenc pressure followed by another d1st1llat10n 
was distilled for 2.5 h (35" -126' C.), and 100 mL of under re?uced pressure to yield ~he e~amine as a pale 
distillate was collected. Heating was momentarily 55 yellow oil (12.7 g, 97.0%), bp 167 -169 C./0.2 mm Hg. 
stopped, and the distillation head, condenser and re- IR (film) cm-I 1650 (C=C-N); 1H NMR (DCCl3) 
ceiver were removed and replaced with a condenser. 61.79 [bs, 4 H, H(9,10)], 2.30 [bs, 2 H, H(3)], 2.56 [t, 2 H, 
The mixture was heated at reflux for 6 h. A brown H(2)], 3.00 [bs, 2 H, H(8,11)], 3.05 [bs, 2 H, H(6)], 3.54 
reaction mixture was poured into a 250 mL Erlenmeyer (s, 2 H, CH2Ph), 4.16 [bs, 1 H, H(5)], 7 .26-7 .33 (m, 5 H, 
flask which was allowed to cool to RT (1 h) and then 60 Ar-H); 13C NMR (DCCb) ppm 24.69 [t, C(9,10)], 
was placed in an ice bath (1 h) to yield acid (46) as a 28.31 [t, C(3)], 47.10 [t, C(8,l l)], 50.07 [t, C(2)], 52.94 [t, 
white solid. This white solid was filtered off using a C(6)], 62.68 (t, CH2Ph), 90.24 [d, C(5)], 126.64, 127.88, 
Buchner funnel under suction (aspirator) and was then 128.92, 138.61 (Ar-C), 141.29 [s, C(4)]. . 
washed with cold H2O (50 mL) to afford, after drying Into a 250-mL, three-necked, round-bottomed flask 
(Abderhalden, 78' C., 12 h/0.2 mm Hg, P20s), acid 65 equipped with a heating mantle, magnetic stirrer, stan-
(19.1 g, 46.3%); mp 96'-97' C. The mother liquor was dard condenser, dropping funnel and a N2 inlet were 
concentrated to about 75 mL and then cooled to RT placed a solution of the above enamine [9.9 g, 40 mmol 
(0.5 h) [followed by an ice bath (0.5 h)] to yield a second in CH3CN (50 mL)] and triethylamine (11.6 g, 9.1 g, 90 
5,084,572 
15 
mmol). The resulting mixture was heated at reflux, and, 
to the boiling solution was added dropwise a solution of 
the dibromo ester ( 4 7, 11.1 g, 40 mmol) in CH3CN (20 
mL) over a period of0.5 h. During addition, triethylam-
monium bromide precipitated as a white solid, and the 5 
reaction mixture turned brown. Heating was continued 
for 3.5 h after the addition was complete. Solvent was 
removed (rotary evaporator) to yield a dark brown oil 
16 
127.84, 129.91, 134.21 (Ar-C), 172.35 (CO2Et). Anal. 
Calcd. for C20H21NO2S2: C, 63.66; H, 7.16; S, 16.97. 
Found: C, 63.99; H, 7.08; S, 17.23. 
EXAMPLEXXI 
Ethyl 
3-Benzyl-9, 9-( 1,3-dithiolan-2-y l)-3-azabicyclo[3 .3 .1 ]no-
nane-7-( endo )-carboxy late Hydroperchlorate (14) 
to which was added H2O (50 mL). The mixture was 
extracted with HCCJ3 (4X50 mL). The organic layers 10 Into a 250-mL Erlenmeyer flask equipped with a 
were combined and washed successively with HCI (lN, magnetic stirrer were placed the thioketal (38, 1.5 g, 4 
2X50 mL), NaHCO3 (saturated aqueous, 2X50 mL) mmol), anhydrous ether (150 mL), and absolute ethanol 
and NaCl (saturated, 2 x 50 mL). After drying (anhy- (5 mL). The resulting solution was cooled in an ice bath 
drous Na2SO4), the solution was filtered and evapo- for 0.5 h. To this cooled solution was added dropwise 
rated (rotary evaporator) to yield the crude ketone (20) 15 HCIO4 (60%, 0.85 g, 5 mmol) over a period of 0.5 h. 
as a dark brown oil. This dark brown oil was purified by During the addition a white solid precipitated. The 
column chromotography over silica gel (150 g, 3.8 resulting mixture was stirred in an ice bath for another 
cm X 61 cm; 1 mL/min) using 10% EtOAc in hexanes as 1 h, after the addition was complete, and then for 2 h at 
the eluant to yield ketone (20) as a pale yellow, viscous RT. The white solid obtained by filtration was recrys-
oil (4.1 g, 33.0%). Rp0.49 in 9:1 hexanes:EtOAc. IR 20 tallized (isopropyl alcohol) to yield the thioketal hy-
(filni) cm-11730 (C=O); 1H NMR (DCCl3) 61.30 (t, 3 droperchlorate (14) as white needles (1.7 g, 90.0%); mp 
H, CH3), 2.18 [dd, 2 H, H(6,8)ax, 1=6.9, 15.9 Hz], 2.29 153°-154° C. IR (KBr) cm- 1 3400 (N-H), 1700 (CO-
[bs, 2 H, H(l,5)], 2.44 [m, 3 H, H(6,8),qand H(7),xo], 2.82 2Et), 1100 (Cl-O); 1H NMR (DCCl3) 61.30 (t, 3 H, 
[dd, 2 H, H(2,4)ax, 1=6.0, 14.4 Hz], 3.04 [d, 2 H, CH3), 2.05 [d, 2 H, H(6,8)ax, 1=16.1 Hz], 2.36 [bs, 2 H, 
H(2,4),q, 1 = 10.6 Hz], 3.56 (s, 2 H, CH2Ph), 4.22 (q, 2 H, 25 H(l,5)], 2.71 [m, 2 H, H(6,8),q], 3.33 (m, 4 H, SCH2), 
OCH2), 7.17-7.30 (m, 5 H, Ar-H); 13C NMR (DCCb) 3.50 [m, 2 H, H(2,4)ax], 3.68 (d, 2 H, CH2Ph), 7.43-7.60 
ppm 14.35 (q, CH3), 33.21 [t, C(6,8)], 37.75 [d, C(7)], (m, 5 H, Ar-H), 10.30 (bs, I H, N-H); 13C NMR 
46.61 [d, C(l,5)], 58.06 (t, CH2Ph), 60.34 (t, OCH2), (DCCJ3) ppm 13.79 (q, CH3), 28.42 [t, C(6,8)], 29.53 [d, 
127.26, 128.09, 129.50, 135.10 (Ar-C), 172.40 (s, CO- C(7)], 39.18 [d, C(l,5)], 39.51, 39.88 (t, SCH2), 56.60 [t, 
2Et), 215.92 _(C=O). The oil, ~ery ~lightly crude (~0), 30 C(2,4)], 61.81 (t, CHiPh), 63.67 (t, OCH2), 68.96 [s, 
was u~ed witho~t further punficat10n for succ~e~mg C(9)], 127.84, 129.93, 130.31, 131.57 (Ar-C), 183.05 (s, 
s~eps smce the 01! decomposed upon attempted d1st11Ia- co2Et). Anal. Calcd. for c 20tt28cJNO6s2: c, 50.26; H, 
tion. 5.86; N, 2.93. Found: C, 50.24; H, 6.12; N, 2.94. 
EXAMPLE XX EXAMPLE XXII 
35 
Ethyl 
3-Benzy 1-9, 9-( l ,3-dithiolan-2-yl)-3-azabicyclo[3. 3.1 ]no-
nane-7-( endo )-carboxylate (38) 
Ethyl 
3-Benzyl-3-azabicyclo[3.3.1 ]nonane-7-(endo )-carboxy-
late Hydroperchlorate (13) 
Into a 100-mL, three-necked, round-bottomed flask 
equipped with a magnetic stirrer, standard condenser, 40 ESter (38) (1.89 g, O.oo5 mo!), ethanol (200 mL), and 
dropping funnel, Ni inlet and an ice-bath were placed Raney nickel (about 20 mL of a wet solid) were heated 
the ketone (20, 3.01 g, 10 mmol), 1,2-ethanedithiol (2 together at reflux for 18 hours, and the mixture was 
mL, 2.25 g, 24 mmol), and dry HCCb (50 mL). The allowed to cool. After the mixture was filtered, the 
resulting mixture was cooled to o•-5• c. in an ice bath. solvent was evaporated to a viscous oil. The oil was 
Freshly distilled BF3 etherate (4 mL, 2.2 g, 15 mmol) 45 treated with a saturated brine solution, and the resulting 
was added dropwise over a period of0.5 h. The reaction mixture was extracted with chloroform (3 X 50 mL). 
mixture was stirred at o•-5° c. for J hand then at RT Evaporation of the solvent gave a colorless oil (0.97 g, 
for 8 h. To the resulting mixture was added HCCJ3 (25 68.0%). Thus, slightly crude ethyl 3-benzyl-3-azabicy-
mL), and the solution was successively washed with clo[3.3.l]nonane-7-(endo)-carboxylate was used in the 
NaOH (IN, 3 X 50 mL) and NaCl (saturated, 50 mL). 50 next step without further purification. 
After drying (anhydrous Na2SO4), the solution was Into a 250 mL Erlenmeyer flask equipped with mag-
filtered and evaporated (rotary evaporator, aspirator) to netic stirrer were placed the above ester (0.95 g, 3 
yield the crude thioketal (38) as a pale yellow, viscous mmol), anhydrous ether (150 mL), and absolute ethanol 
oil, which was purified by column chromatography (5 mL). The resulting solution was cooled in ice bath 
over silica gel (105 g) using 10% EtOAc in hexanes as 55 and to the chilled solution was added dropwise HCIO4 
the eluant. The thioketal was obtained as a colorless oil (60%, 0. 75 g, 4.5 mmol) over a period of 0.5 h. During 
which crystallized out as a white solid upon standing at the addition, a white solid precipitated. The resulting 
RT (12 h). This white solid was recrystallized (hexanes) mixture was stirred in ice bath for 1 h, after the addition 
to yield solid thioketal (38) as white needles (1.6 g, was complete, and then for 2 h at RT. Filtration and 
42.0%, mp 76°-78° C.). IR (KBr) cm- 1 1715 (CO2Et); 60 recrystallization (isopropyl alcohol) yielded the hy-
lH NMR (DCCb) 61.30 (t, 3 H, CH3), 1.90 [bs, 2 H, droperchlorate (13) as colorless platelets (0.87 g, 
H(l,5)], 2.34 [bd, 2 H, H(6,8)ax], 2.47 [m, 1 H, H(7)], 68.0%); mp 130°-131° C. IR (KBr) cm-13440 (N-H), 
2.68-2.83 [m, 6 H, H(6,8),q, H(2,4)ax and H(2,4),q], 1700 (CO2Et), 1100 (Cl-O); 1H NMR (DCCl3) 61.30 
3.10-3.17 (m, 4 H, SCH2), 3.44 (s, 2 H, CH2Ph), 4.19 (q, (t, 3 H, CH3), 1.61 [bd, 1 H, H(9)endo], 1.87 [d, 2 H, 
2 H, OCH2), 7.12-7.33 (m, 5 H, Ar-H); i3C NMR 65 H(6,8)ax, 1 = 12 Hz], 2.05 [bd, 1 H, H(9)exo], 2.16-2.31 
(DCCl3) ppm 14.36 (q, CH3), 30.25 [t, C(6,8)], 36.71 [d, [m, 4 H, H(l,5) and H(6,8),q], 2.91-2.98 [m, 1 H, H(7)], 
C(7)], 38.2 I, 38.64 (t, SCH2), 42.10 [d, C(l,5)], 54.92 [t, 3.35-3.48 [m, 4 H, H(2,4)ax and H(2,4),q], 4.32 (q, 2 H, 
C(2,4)], 60.14 (t, CH2Ph), 60.27 (t, OCH2), 127.00, OCH2), 4.50 (d, 2 H, CH2Ph), 7.38-7.68 (m, 5 H, 
17 
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Ar-H); 13C NMR (DCCl3) ppm 13.79 (q, CH3), 25.74 
[d, C(l,5)], 27.85 [t, C(6,8)], 31.91 [d, C(7)], 55.96 [t, 
C(2,4)], 61.68 (t, CH2Ph), 63.05 (t, OCH2), 128.60, 
129.98, 131.25, (Ar-C), 182.93 (s, CO2Et). Anal. Calcd. 




(DCCb) 60.96 (d, 3 H, CH3, 1 =6.4 Hz), 1.06 (d, 3 H, 
CH3, 1 =6.5 Hz), 1.62-1.75 [m, 3 H, H(5) and H(9)], 1.96 
[bs, 1 H, H(l)], 2.43 [bd, 1 H, H(4)ax, 1=9.7 Hz], 2.51 
[bd, 1 H, H(6)ax, 1 = 10.5 Hz], 2.62 [heptet, 1 H, 
CH(CH3)2, 1 =6.4 Hz], 2.74 [bd, 1 H, H(6)eq, 1 =9.9 Hz], 
3.00-3.09 [m, 2 H, H(4)eq and H(2)ax], 3.32 [bd, 1 H, 
H(8)ax, 1 = 13.2 Hz], 3.83-3.94 [m, 7 H, H(8)eq and 
OCH3], 4.77 [bd, 1 H, H(2)eq, 1 = 13.3 Hz], 6.84-6.94 (m, 
3 H, Ar-H); 13C NMR (DCCl3) ppm 16.46, 19.15 7-Isopropyl-3-(3' ,4' ,5 '-trimethoxybenzoyl)-3, 7-
diazabicyclo[3.3.1 ]nonane (35) 10 (CH3), 29.13 [C(l)], 29.86 [C(5)], 32.36 [C(9)], 46.71 
[C(2)], 52.25 [C(4)], 52.65 [C(8)], 54.35 [CH(CH3)2], 
54.68 [C(6)], 55.88, 55.93 (OCH3), 110.50, 119.64, 
130.23, 148.78, 149.39 (Ar-C), 169.90 (C=O). Anal. 
A 25-mL, three-necked, round-bottomed flask was 
equipped with a magnetic stirrer, a standard condenser 
with N2 inlet, a 10-mL addition funnel and two glass 
stoppers. To a mixture of the amine (31, 0.60 g, 3.57 
mmol) in CH2Cli (5 mL) and 10% NaOH (3.58 g, 8.93 15 
mmol) was added dropwise a solution of 3,4,5-trime-
thoxybenzoyl chloride (0.92 g, 3.92 mmol) in CH2Cli (5 
mL) over 15 min. Stirring of the mixture was continued 
for an additional 3 h under N2. An aqueous mixture, 
upon addition of H2O (30 mL), was extracted (CH2Cli, 20 
Calcd. for C19H2sN2O3: C, 68.65; H, 8.49. Found: C, 
68.58; H, 8.47. 
EXAMPLEXXV 
3-(3' ,4' -Dimethoxybenzoyl)-7-isopropyl-3, 7-diazabicy-
clo[3.3. l]nonane Hydroperchlorate (3) 
4 x 25 mL). Combined extracts were dried (Na2so4, 2 A 50-mL Erlenmeyer flask was equipped with a mag-
h), filtered, and concentrated to give a viscous yellow netic_stirrer and a~ ice bath. To a chilled (5° _C.), stirred 
oil. Chromatography of the oil was performed on neu- solution of the amide (34, 0.30 g, 0.90 mmol) m ether (30 
tral alumina (74 g, 1.7 cmX32 cm) using 60:40 ethyl mL) was added dropwise a solution of HCIO4 (60%, 
acetate/hexanes as eluant. Fractions (Rp0.34) were 25 0.18 g, 1.08 mmol) in isopropyl alcohol (1 mL) over 10 
saved and concentrated (rotary evaporator then vac- min. A white precipitate resulted which was filtered 
uum pump, overnight, RT/0.2 mm Hg) to give 1.02 g and then stirred in hot CH3OH (10 mL) for 20 min. The 
(79.1%) of off-white solid (35); mp 67.5°-69.5° C. IR mixture was filtered and dried (Abderhalden, P2O5, 
(KBr) cm-I 3055 (Ar C-H), 2985, 2955, 2910, 2890, overnight, RT/0.2 mm Hg) to give 0.27 g (69.2%) of 
2780 (C-H), 1620 (C=O); IH NMR (DCCb) 60.96 (d, 30 white solid (3); mp 235°-236° C. (dee). IR (KBr) cm-I 
3 H, CH3, 1=6.5 Hz), 1.09 (d, 3 H, CH3, 1=6.7 Hz), 3130 (N-H), 3010 (Ar C-H), 2975, 2945, 2920 
1.64-1.79 [m, 3 H, H(5) and H(9)], 2.05 [bs, 1 H, H(l)], (C-H), 1635 (C=O), 1095 (Cl-O); IH NMR (DMSO-
2.44 [bd, 1 H, H(4)ax, 1 = 10.6 Hz], 2.57 [bd, l H, H(6)ax, d6, 80° C.) 61.33 (d, 6 H, CH3, 1 =6.7 Hz), 1.74 [bd, 1 H, 
1 = 10.8 Hz], 2.66 [heptet, l H, CH(CH3)2, 1 =6.6 Hz], H(9), 1 = 12.8 Hz], 1.91 [bd, 1 H, H(9), 1 = 13.2 Hz], 2.27 
2.71 [bd, l H, H(6)eq, 1=11.0 Hz], 3.02-3.07 [m, 2 H, 35 [bs, 2 H, H(l,5)], 3.12 [bd, 2 H, H(6,8)ax, 1=13.7 Hz], 
H(4)eq and H(2)ax], 3.31 [bd, 1 H, H(8)ax, 1 = 13.2 Hz], 3.19-3.28 [m, 2 H, H(2,4)ax], 3.42-3.56 [m, 3 H, H(6,8)eq 
3.80-3.92 [m, 10 H, H(8)eq and OCH3], 4.77 [bd, 1 H, and CH(CH3)2], 3.78, 3.81 (twos, 6 H, OCH3), 3.97 [bd, 
H(2)eq, 1=13.5 Hz], 7.29 (s, 2 H, Ar-H); 13C NMR 2 H, H(2,4)eq, 1=13.6 Hz], 6.94-7.03 [m, 3 H, Ar-H], 
(DCCl3) ppm 15.87, 19.42 (CH3), 29.02 [C(l)], 29.78 7.81 (bs, 1 H, N-H); 13C NMR (DMSO-d6, so· C.) 
[C(5)], 32.35 [C(9)], 46.64 [C(2)], 51.73 [C(4)], 52.48 40 ppm 16.34 (CH3), 26.81 [C(l,5)], 27.80 [C(9)], 49.06 
[C(8)], 54.39 [CH(CH3)2], 54.95 [C(6)], 56.13, 60.86 [C(2,4)], 52.40 [C(6,8)], 55.88, 55.92 (OCH3), 59.97 
(OCH3), 103.83, 133.32, 133.21, 138.22, 153.21 (Ar-C), [CH(CH3)2], 111.85, 112.10, 120.44, 128.68, 148.74, 
169.66 (C=O). Anal. Calcd. for C20H30N2O4: C, 66.27; 150.26 (Ar-C), 172.97 (C=O). Anal. Calcd. for 
H, 8.34. Found: C, 66.04; H, 8.32. c 19H29ClN2O7: C, 52.72; H, 6.75. Found: C, 52.35; H, 
EXAMPLE XXIV 45 6.77. 
J-(3' ,4' -Dimethoxybenzoyl)-7-isopropyl-3, 7-diazabicy-
clo[3.3. l]nonane (34) 
EXAMPLE XXVI 
3-Benzenesulfonyl-7-isopropyl-3, 7-diazabicyclo[3.3.1-
]nonane (36) A 25-mL, three-necked, round-bottomed flask was 
equipped with a magnetic stirrer, a standard condenser 50 
with a N2 inlet, a 10-mL addition funnel, and two glass A 50-mL, three-necked, round-bottomed flask was 
stoppers. To a mixture of the amine (31, 0.60 g, 3.57 equipped with a magnetic stirrer, a standard condenser 
mmol) in cH2Ch (5 mL) and 10% NaOH (3.58 g, 8.93 with a N2inlet, an ice bath, a 10-mL addition funnel, and 
mmol) was added dropwise a solution of 3,4-dimethoxy- a glass stopper. To a stirred, ice cold (5° C.) mixture of 
benzoylchloride(0.80g,3.92mmol)inCH2Ch(lOmL) 55 the amine (31, 1.03 g, 6.12 mmol) and NaOH pellets 
over 15 min. Stirring of the mixture was continued for (97%, 0.76 g, 18.4 mmol) in H2O (7 mL) and CH2Ch (5 
an additional 3 h under N2. An aqueous mixture, formed mL) was added dropwise a solution of benzenesulfonyl 
upon addition ofH2O (30 mL), was extracted (CH2C]i, chloride (2.16 g, 12.2 mmol) in CH2Cli (5 mL) over 30 
4X25 mL). Combined extracts were dried (Na2SO4, 2 min. Stirring of the mixture was continued for an addi-
h), filtered and concentrated to give a viscous yellow 60 tional 17.5 h at RT. The reaction mixture was then 
oil. Chromatography of the oil was performed on neu- partitioned between H2O (30 mL) and CH2Ch (30 mL) 
tral alumina (74 g, 1.7 cmX32 cm) using 60:40 ethyl followed by basification (pH~ 12) of the aqueous phase. 
acetate/hexanes as eluant. Fractions (Rp0.31) were Extracts (CH2Ch, 3X30 mL) of the remaining water 
saved and concentrated (rotary evaporator then vac- layer were combined with the initial organic layer. The 
uum pump, overnight, RT /0.2 mm Hg) to give 0.87 g 65 solution was washed with 10% NaOH (30 mL) and then 
(73.1%) of off-white solid (34); mp 67.5°-69.5° C. IR saturated NaCl (30 mL); it was dried (Na2SO4, over-
(KBr) cm-I 3055 (Ar C-H), 2950, 2915, 2845, 2820, night), filtered, and concentrated to give an orange 




on silica gel (39 g, 1.6 cm X 62 cm) using 10% magnetic stirrer, a heating mantle, a standard con-
CH3OH/CH2Cl2. Fractions (Rp0.44) were saved, denser, a lower take-off condenser with a N2 inlet, and 
concentrated, and reeluted on neutral alumina (90 g, 2.5 two glass stoppers. A heating temperature of 200' -210" 
cmX 18 cm) employing ethyl acetate as eluant. Frac- c. for 5 h was produced by boiling tetralin (bp 207' C.) 
tions (Rp0.53) were saved and concentrated. A col- 5 in the jacket. After cooling to RT, the solution was 
ored impurity persisted which was removed by again diluted with chilled water (100 mL) and extracted with 
eluting over silica gel (21 g, 1.6 cmX33 cm) using 5% ether (4x5o mL). Combined extracts were washed 
CH3OH/CH2Cli as eluant. Fractions (Rf=0.34) were 
combined and concentrated (rotary evaporator then with 10% NaOH (50 mL) and saturated NaCl (50 mL), 
vacuum pump, overnight, RT/0.2 mm Hg) to give 0.54 10 dried (Na2SO4, overnight), filtered, and concentrated to 
g (28.6%) of white solid (36); mp 85.5' -86.5' c. IR a yellow oil (0.8 g). Dissolution of the oil in ether (50 
(KBr) cm-1 3060 (Ar C-H), 2960, 2910, 2890, 2865, mL) via magnetic stirring and cooling (5° C.) with an 
2820 (C-H), 1585 (C=C), 1340, 1170 (S=-0), 760, 720 external ice bath was followed by dropwise addition of 
(C-H out of plane, mono); IH NMR (DMSO-d6) 60.88 a solution ofHCIO4(60%, 1.08 g, 6.45 mmol) in isopro-
(d, 6 H, CH3, 1=6.5 Hz), 1.40 [bs, 2 H, H(9)], 1.94 [bs, 15 pyl alcohol (3 mL) over 10 min. Stirring of the mixture 
2 H, H(l,5)], 2.35 [bd, 2 H, H(6,8)a:c, 1 = 10.3 Hz], 2.53 ari additional 10 min, filtering the precipitated salt, and 
[heptet, 1 H, CH(CH3)2, 1=6.5 Hz], 2.69 [bd, 2 H, then washing the latter with ether (~50 mL) gave an 
H(6,8)eq, 1 = 10.3 Hz], 2.89 [dd, 2 H, H(2,4)a:c, 1 = 11.2 off-white solid. Dissolving the salt in hot 95% EtOH 
Hz, J' =4.5 Hz], 3.36 [d, 2 H, H(2,4)eq, 1 = 10.9 Hz], and decolorizing the solution with Norit, followed by 
7.58-7.75 (m, 5 H, Ar-H); 13C NMR (DMSO-d6) ppm 20 filtering, and cooling, afforded 0.91 g (63.6%) of salt (8) 
17.57 (CH3), 27.39 [C(l,5)], 28.95 [C(9)], 48.88 [C(2.4)], as a white solid; mp 281° -282.5° C. IR (KBr) cm- 1 3060 
52.66 [C,(6,8)], 53.42 [CH(CH3)2], 126.90, 129.01, (N-H), 3000, 2960, 2935 (C-H), 1090 (Cl-O); IH 
132.36, 136.79 (Ar-C). Anal. Calcd. for C16ff24N2O2S: NMR (DMSO-d6) 61.28 (d, 6 H, CH3), 1.76 [d, 1 H, 
C, 62.31; H, 7.85. Found: C, 62.48; H, 7.69. H(9), 1 = 13.3 Hz], 1.91 [d, I H, H(9), 1 = 12.9 Hz], 2.35 
EXAMPLE XXVII 25 [bs, 2 H, H(l,5)], 2.78 [bd, 2 H, H(2,4)ax, 1=12.2 Hz], 
7-Isopropyl-3-thia-7-azabicyclo[3.3. l}nonan-9-one (26) 
3.14 [bd, 2 H, H(2,4)eq, 1 = 13.6 Hz], 3.29-3.57 [m, 3 H, 
H(6,8)a:c and CH(CH3)2], 3.62 [d, 2 H, H(6,8)eq, 1 = 12.7 
A three-necked, 300-mL, round-bottomed flask was Hz], 9.07 (bs, 1 H, N-H); 13C NMR (DMSO-d6) ppm 
equipped with a magnetic stirrer, a heating mantle, a 16.19 (q, CH3), 25.51 [d, C(l,5)], 28.35 [t, C(9)], 30.69 [t, 
" standard condenser with a N2 inlet, and two glass stop- 30 C(2,4)], 52.36 [t, C(6,8)], 58.66 [d, CH(CH3)2]; 15N 
pers. A mixture containing isopropylamine (2.96 g, 50 NMR (DMSO-d6) ppm 58.47 [N(7)]. Anal. Calcd. for 
mmol), paraformaldehyde (12.~1- g, ~ m~ol), a~d C 10H2oCINO4S: C, 42.03; H, 7.05. Found: C, 42.10; H, 
CH3OH (188 mL) was made ac1d1c with glacial acetic 7 18 
acid (4.5 g, 75 mmol). In one portion, 4-thianone (44, · · 
5.81 g, 50 mmol) was added followed by stirring at 35 
reflux for 21 h. Evaporation of the solvent gave a red 
oil, which was diluted with H2O (200 mL) and ex-
tracted with ether (2 X l 00 mL ), the latter being dis-
EXAMPLE XXIX 
7-(3' -Iodobenzyl)-3-thia-7-azabicyclo[3.3. l}nonan-9-one 
(25) 
carded. Basification (pH~ 12) of the aqueous layer by A 100 mL, three-necked, round-bottomed flask was 
the addition of NaOH pellets (3.0 g, 75 mmol) resulted 40 equipped with a magnetic stirrer, a heating mantle, a 
in the formation of a yellow suspension which was standard condenser with a N2 inlet, and two glass stop-
extracted with CH2Cli(4X 100 mL). Combined extracts pers. A mixture containing 3-iodobenzylamine (1.19 g, 
were dried (MgSO4, overnight), filtered, and concen- 5.10 mmol), paraformaldehyde (1.22 g, 40.8 mmol), and 
trated to afford a yellow oil which solidified upon cH3QH (30 mL) was made acidic with glacial acetic 
standing. This solid was digested in 250 mL of Skelly B 45 acid (0.46 g, 7 .65 mmol). In one portion, 4-thianone ( 44, 
(bp 60•-68• C.) for 30 min, and the supernatant was 0.59 g, 5.10 mmol) was added and the resulting mixture 
decanted. Evaporation of the solvent, followed by heat- was heated under N2 at reflux for 21 h. Evaporation of 
ing th~ cru_de solid in vacuo (95'-l ~o• C./0:3 mm_Hg) in the solvent gave a reddish oil, which was dissolved in 
a subhmat1on apparat~s g?ve a sticky white sohd (mp H O (40 mL). Basification (pH~ 13) of the solution b 54° -57° C.). Recrystalhzat1on (Skelly B) afforded 4.15 g 50 2 . . . . Y 
(41.6%)ofwhiteflakesofketone(26);mp59•-60•C.IR the dr~pw1se ad~1tJon of IO~ NaO:8 resulted m the 
(KBr) cm- I 2965 2935 2900 2875 2805 (C-H) 1730 formation of a m1lky suspension which was extracted 
(C=-0); IH NMR (DCCb) 6'1.04 (d, 6 H, CHJ, j=6.7 with ether (5X4:<J mL). Combined extracts were dried 
Hz), 2.75-2.90 [m, 5 H, ring protons, CH(CH3)2, and (Na2SO4, overnight), filtered, and concentrated to a 
H(l,5)], 3.05-3.13 (m, 4 H, ring protons), 3.24-3.29 (m, 55 yellow oil. Di~esti?n of the oil. occurred in Skelly B 
2 H, ring protons); 13C NMR (DCCb) ppm 18.30 (q, (125 mL, bp 60 -68 C.) for 30 m1n, and the supernatant 
CH3), 34.16 [t, C(2,4)], 47.52 [d, C(l,5)], 53.76 [d, was decanted. Further digestion of the residual material 
CH(CH3)2], 54.16 [t, C(6,8)}, 213.68 (s, C=-0); 15N was effected in pentane (2X 125 mL) for 30 min. Com-
NMR (DCCb) ppm 39.27 [N(7)]. Anal. Calcd. for bined supernatant extracts were concentrated (rotary 
C10H17NOS: C, 60.26; H, 8.60. Found: C, 60.40; H, 8.65. 60 evaporator the vacuum pump, overnight, RT/0.2 mm 
EXAMPLE XXVIII Hg) to ~ive 0.84 g (57.5:1') ofa slightly c~de "'.isc~us oil 
(25) which was used without further punficat1on m the 
next step. IR (film) cm-1 3055 (Ar C-H), 2930, 2825 
(C-H), 1735 (C=-0), 885, 790, 695 (C-H out of plane, 
meta); 1H NMR (DCCl3) 62.72-3.18 [m, 10 H, ring 
protons and H(l,5)], 3.51 (s, 2 H, ArCH2), 7.07-7.71 (m, 
4 H, Ar-H); 13C NMR (DCCl3) ppm 35.05 [C(2,4)], 
46.95 [C(l,5)], 58.20 [C(6,8)}, 60.69 (ArCH2), 94.43, 
7-Isopropyl-3-thia-7-azabicyclo[3.3. l}nonane 
Hydroperchlorate (8) 
To a mixture of KOH pellets (85%, 3.96 g, 60 mmol) 65 
and the ketone (26, 1.0 g, 5 mmol) in triethylene glycol 
(25 mL) was added hydrazine (95%, 1.69 g, 50 mmol) in 
one portion in a 70-mL, jacketed flask equipped with a 
21 
5,084,572 
127.98, 130.23, 136.44, 137.64, 140.63 (Ar-C), 213.00 
(C==O). 
EXAMPLEXXX 
7-(3' -Iodobenzyl)-3-thia-7-azabicyclo[3.3. l]nonane 
Hydroperchlorate (9) 
22 
min), and the supernatant extracts were concentrated 
and then distilled (190'-215" C./10- 5 mm Hg) to give 
an oil. Crystallization of the oil was induced by dis-
solving the oil in hot pentane (800 mL) and then chilling 
5 (-10' C.) the solution to give 14.66 g (45.8%) of white, 
crystalline ketone (19); mp 82.5' -83.5' C. Concentra-
To a mixture of KOH pellets (85%, 0.48 g, 7.2 mmol) tion (hot plate) of the mother liquor to ~80 mL pro-
and the ketone (25, 0.224 g, 0.60 mmol) in triethylene duced a second crop (0.81 g, 2.5%) of 3,7-dibenzyl-3,7-
glycol (10 mL) was added hydrazine (95%, 0.20 g, 6.0 diazabicylco[3.3.l]nonan-9-one (19); mp 81.5'-82.0' C. 
mmol) in one portion in a 50-mL, jacketed flask 10 The total yield was (15.47 g, 48.3%). 
equipped with a magnetic stirrer, a heating mantle, a A 70-mL, five-necked, jacketed flask was equipped 
standard condenser, a lower take-off condenser with with a magnetic stirrer, a heating mantle, a standard 
N2 inlet, and two glass stoppers. A heating temperature condenser, a lower take-off condenser with a N2 inlet, a 
of 140' -150' C. for 4 h was produced by boiling 0 - thermometer, and two glass stoppers. After the addition 
xylene (bp 144° C.) in the jacket. After cooling to RT, 15 of the ketone (19, 2.0 g, 6.24 mmol), KOH pellets (85% 
the solution was diluted with cold H2O (30 mL) and , 4.94 g, 56.1 mmol) and hydrazine (95%, 2.11 g, 32.1 
was then extracted with ether (4X30 mL). Combined 
t h d • h tom N OH (30 L) d mmol) in triethylene glycol (40 mL) were added. The ex racts were was e wit ,o a m an . . . · . apparatus was flushed with N2, and the rmxture was 
saturated NaCl (30 mL), dn7d (Na2S04, ?vern1ght), heated at 140' -150" C. for 4 h using boiling o-xylene (bp 
filtered, and concentrated to give a yellow 011 (209 mg). 20 , . . . . 
Dissolution in ether (25 mL) via magnetic stirring and. 144 C.) m the Jacket._ ~oolmg t~e solution to RT was 
cooling (5" C.) in a 50-mL Erlenmeyer flask equipped follo~ed by the add1t10n of chilled water (80 m:1--)-
with an external ice bath followed by the dropwise Combmed extra_cts (ether, 3 X 75 mL) of the su_spens1on 
addition of a solution of HCJO4 (60%, 0.15 g, 0.87 were wash~d with saturated NaCl (75 mL), dned (Na2. 
mmol) in isopropyl alcohol (1 mL) over 10 min. Filtra- 25 S?4, overnight), filter7d, a~d concentrated to a yellow 
tion of the precipitate and then washing the latter with 011 (1.83 g, 95. 7%) which displayed no carbonyl stretch 
ether ( ~ 50 mL) gave a solid which changed to an oil. in the IR spectrum. This oil, that is amine (37), was used 
This oil was dissolved in 95% EtOH, and the solution without further purification. 
was decolorized with Norit, filtered, and left to stand at A 100-mL, three-necked, round-bottomed flask was 
RT overnight. White crystalline salt (9) was collected 30 equipped with a magnetic stirrer, a condenser with a N2 
(77 mg, 27.7%); mp 169.5'-170' C. IR (KBr) cm-13045 inlet, a 50-mL addition funnel, and a glass stopper. To a 
(Ar C-H), 2950, 2915, 2825 (C-H), 1570 (C=C), 1085 solution of Nal04 (2.49 g, 11.62 mmol) in H2O (22.4 
(Cl-O), 780,765 (C-H out of plane, meta); 1H NMR mL) was added Ru02xH2O (0.1 g) which produced a 
(DMSO-d6) ol.81 [m, 2 H, H(9)], 2.36 [bs, 2 H, H(l,5)], dark green solution. After the apparatus was flushed 
2.70 [d, 2 H, H(2,4)ax, J = 13.6 Hz], 3.09 [d, 2 H, 35 with N2, a solution of the amine (37, 0.89 g, 2.9 mmol) 
H(2,4),q, J = 13.7 Hz], 3.35 [m, 2 H, H(6,8)ax]3.58 [d, 2 in CCI4 (16 mL) was added in one portion to produce a 
H, H(6,8),q, 1 = 11.9 Hz], 4.22 (s, 2 H, ArCH2), 4.24 (s, black mixture. The mixture was stirred at RT for 72 h 
1 H, ArCH2), 7.32-8.03 (m, 4 H, Ar-H), 9.20 (bs, 1 H, and then the organic layer was separated. Further ex-
N-H); 13C NMR (DMSO-d6) ppm 25.78 [C(l,5)], traction of the aqueous phase was effected with CCJ4 
28.48 [C(9)], 30.65, [C(2,4)], 56.53 [C(6,8)], 60.04 40 (20 mL) followed by HCCl3 (3X20 mL). Combined 
(ArCH2), 95.40, 129.93, 131.08, 132.47, 138.18, 138.93 extracts were treated with isopropyl alcohol (3 mL) to 
(Ar-C); 15N NMR (DMSO-d6) ppm 54-17 [N(7)J. destroy excess oxidant and were then filtered through a 
Anal. Calcd. for C14ff19CIINO4S: C, 36.58; H, 4.17; N, r d Af h" th · h 5m d' 
3.05· I 27_60, Found: C 36_87. H 4_15. N 2_99. I 27_64_ ce_ 1te pa . ter was mg e extracts wit_ -10 so rnm ' ' ' ' ' ' ' ' ' thiosulfate (50 mL), the extracts were dned (Na2SO4, 
EXAMPLE XXXI 45 overnight), filtered, and concentrated to a yellow oil. 
3, 7-Dibenzyl-3, 7-diazabicyclo[3.3. l]nonan-2-one (19) Elution of the oil on neutral alumina (84 g, 2.4 cm X 19 
cm) using first ether (50 mL) and then ethyl acetate (150 
A_ 500-m1;-, three-neck7d, r~und-botto~ed flask was mL) as eluants gave a solid material (R_r=0.60, ethyl 
equipped with a magnetic stirrer, a heatmg mantle, a acetate). This material was recrystallized by dissolving 
standard condenser with a N2 inl~t, a 250-mL addit~on SO in ether (6 mL) and then refrigerating at -10" c. for 2 
funnel, and a glass stopper. A mixture of benzylamme h; this solution was placed in a diffusion chamber of 
(~0.71 g'. 100_ mmol), HCI (37%, 4.93 g, 50 mmol), gla- pentane for 1 h. Filtration afforded (0.27 g, 28.9%) of 
c1al acetic acid (6.0 _g, 100 mmol) and paraformaldehyde the lactam (l 7); mp 96.0" -96.5" c. IR (KBr) cm- I 3070, 
(6.31 g, 210 mm~!) m ~J:i30H (lOO mL)was brou~ht to 
55 
3050, 3020 (Ar C-H), 2945, 2920, 2855, 2785, 2760 
gentl~ reflux with st1rn~g ~n?er N2 over 15 mm. A (C-H) 1645 (C==O) 1600 (C=C) 740 710 (C-H out solution of 1-benzyl-4-pipendmone (43, 18.93 g, 100 ' . 1 ' ' mmol) and glacial acetic acid (6.01 g, 100 mmol) in of plane, mono), H NMR (DCCl3) 81.69 [d, 1 H, H(9), 
CH3OH (100 mL) was then added dropwise over 1 h 1=12.7 H_z], 1.88 [d, 1 H, H(9), 1=12.7 Hz], 2:05-2.09 
and this was followed by a period of reflux for an addi- [m, 2 H, nng prot~n and H(l)], 2.24 (dd, 1 H'. nng pro-
tional 18 h. Upon cooling the mixture to RT, the solvent 60 ton, 1 = 10.74 Hz, 1 =2.23 Hz~, 2.66 [m, 2 H, nng proton 
was removed and the resulting red oil was redissolved and H(5)], 3.08 [d'. 1 H, nng proton, J = 11.8 Hz], 
in H2O (100 mL). Combined extracts (ether, 2X JOO 3.25-3.36 [m, 3 H, nng proton and H(l l)], 3.59 [d, 1 H, 
mL) of the acidic aqueous layer were discarded. Basifi- H(l l), J = 13.2 Hz], 4.24[d, 1 H, H(lO), 1 = 14.8 Hz], 5.06 
cation of the chilled (10° C., ice water bath) water layer [d, 1 H, H(lO), 1 = 14. 7 Hz], 7.08-7.38 (m, 10 H, Ar-H); 
to pH~ 12 was affected by the addition of 10% NaOH. 65 13C NMR (DCCb) ppm 27.94 [C(9)], 28.07 [C(5)], 39.07 
Combined extracts (ether, 4X60 mL) were dried (Na2. [C(l)], 49.84 [C(lO)], 51.60 [C(4)], 57.07 [C(8)], 59.03 
SO4, 1 h), filtered, and concentrated to give a viscous [C(6)], 62.70 [C(l 1)], 126.88, 127.14, 128.17, 128.40, 




Anal. Calcd. for C21H24N2O; C, 78.72; H, 7.55. Found: 
C, 78.39; H, 7.78. 
EXAMPLE XXXII 
7-Benzyl-9,9-dimethoxy-3-thia-7-azabicyclo[3.3. 1 ]no-
nane Hydroperchlorate (11) 
Caution: The use of shields, protective goggles and 
gloves is very strongly recommended when performing 
this experiment. The formation of explosive methyl 
perchlorate is a likely side reaction in this experiment. 
No difficulty was noted when the reaction was per-
formed as described, but this may have been fortuitous. 
A one-necked, 100-mL, round-bottomed flask was fitted 
with a Soxhlet containing 3A molecular sieves (30 g), a 
condenser, a heating mantle, a magnetic stirrer, and a 
heating mantle. The effective cycling volume of the 
trated to approximately 10 mL. Upon cooling to a -10' 
C. overnight, a second crop of salt (12) was obtained 
(89.4 mg, 68.6% total), mp 219°-220° C. (dee). The 
spectral data were as follows: IR (KBr) cm- 1 
5 2800-2600 (N-H), 1100 (CI-O); 1H NMR (DMSO-
d6) 62.35 [bs, 2 H, H(l,5)], 2.90 [d, 4 H, H(2,4,6,8)ax, 
J = 13 Hz], 3.08 [d, 4 H, H(2,4,6,8)eq, J = 13 Hz], 3.14 (s, 
6 H, OCH3), 3.88 (s, 4 H, CH2Ph), 7.38-7.54 (m, 10 H, 
Ar-H), 9.84 (bs, 1 H, N-H); 13C NMR (DMSO-d6) 
10 ppm 33.0 [d, C(l,5)], 47.0 (q, OCH3), 53.8 [t, C(2,4,6,8)], 
59.6 (t, CH2Ph), 95.4 [C(9)], 128.2, 128.4, 129.6, 133.5 
(Ar-C); 15N NMR (DMSO-d6) ppm 52.9 [N(3,7)]. 
Anal. Calcd. for C23H31CIN2O6: C, 59.16; H, 6.69; Cl, 
7.59; N, 6.00. Found: C, 58.98; H, 6.81; Cl, 7.86; N, 6.28. 
15 
EXAMPLE XXXIV 
Soxhlet was approximately 15 mL. The flask was 7-Benzyl-3-thia-7-azabicyclo[3.3.l]nonane 3-0xide (49) 
charged with a solution of the ketone (18, 1.0 g, 4 mmol) . . . . 
in methanol (20 mL) and benzene (20 mL). To this ~ 200-mL flask was equipped _w1th_a magn7t1c stirrer, 
solution was added HCJO4 (60%, 2.0 g, 12 mmol) in one 20 ~ ice bat~, and ~ condens~r with mtro~en mlet. To a 
portion. The apparatus was flushed with Ni and the pale stmed,_ch1lled (5 C.) solution of the amme (2?, 1.4 g, 6 
yellow solution was heated at reflux with stirring and ~mol) m methanol (60 mL) was ~dded dropw1se a solu-
cycling through the Soxhlet for 24 h. The solution was t10n ofNaIO4(1.35 g, 6.3 mmol) m water (15 mL) over 
cooled to RT and concentrated to about 5 mL. Ethyl 30 min. After stirring for one hour, the suspension was 
ether (20 mL) was added, thus precipitating the salt as a 25 filtered and washed with methanol (50 mL); the wash-
powder. This was filtered, washed with ether (5 mL), ings and filtrate were combined and concentrated to a 
and dissolved in hot methanol (20 mL, decolorizing residue which was partitioned between H2CC!i and 
carbon). Trituration with ether (25 mL), followed by water (40 mL each). Additional extracts (HCCl3, 3 X 40 
standing for 24 h, afforded the salt (11) (0.74 g, 46.2%) mL) of the aqueous layer were combined with the initial 
as small white crystals; mp 193 ° -194 ° C. (dee); IR (KBr) 30 extract, and the solution was dried (Na2SO4) and con-
cm-1 2800-2600 (N-H), 1090 (Cl-O); IH NMR centrated to afford an oil which solidified upon stand-
(DMSO-d6) 62.58 [bs, 2 H, H(l,5)], 2.75 [d, 2 H, ing. Recrystallization (HCCl3/pentane) of the solid 
H(2,4)ax, J=l4 Hz], 3.15-3.18 [m, 8 H, H(2,4)eqand gavel.15g(76.9%)ofcrystalline(49);mpl40'-141°C. 
OCH3], 3.38 [dd or bt, 2 H, H(6,8)ax, J = 12 Hz], 3.60 [d, IR (KBr) cm- I 3085, 3065, 3030, 2955, 2920, 2895, 2815, 
2 H, H(6,8)eq, J = 12 Hz], 4.33 (d, 2 H, CH2Ph, J = 5 Hz), 35 1495, 1020, 740, 705; IH NMR (DCCIJ) 61.59 [bd, I H, 
7.49-7.62 (m, 5 H, Ar-H); 13C NMR (DMSO-d6) ppm H(9), J = 13.3 Hz], 1.86 [bd, 1 H, H(9), J = 13.2 Hz], 2.20 
28.8 [t, C(2,4)], 32.2 [d, C(l,5)], 46.6 (q, OCH3), 47.0 (q, [d, 2 H, H(2,4)ax, J = 11.7 Hz], 2.37 bs, 2 H, H(l,5)], 2.62 
OCH3), 54.5 [t, C(6,8)], 60.2 (t, CH2Ph), 95.1 [s, C(9)], [d, 2 H, H(6,8)ax, J = 12.0 Hz], 2. 78 [d, 2 H, H(2,4)eq, 
129.0, 129.5, 130.1, 130.2 (d, Ar-C); 15N NMR J = 11.8 Hz], 3.51 [d, 2 H, H(6,8),q, J = 11.7 Hz], 3.55 [s, 
(DMSO-d6) ppm 53.5 [N(7)]. Anal. Calcd. for 40 2 H, ArCH2], 7.26-7.39 (m, 5 H, Ar-H); 13C NMR 
C26H24CJNO6S: C, 48.79; H, 6.14; Cl, 9.00; N, 3.56; S, (DCClJ) ppm 31.86 [t, C(9)], 32.59 [d, C(l,5)], 57.42 [t, 
8.14. Found: C, 48.73; H, 6.09; Cl, 9.39; N, 3.54; S, 8.40. C(2,4)], 58.59 [C(6,8)], 62.88 (ArCHi), 127.20, 128.39, 
EXAMPLE XXXIII 129.12, 137.67; 15N NMR (DCCl3) ppm 49.37 [N(7)]. 
Anal. Calcd. for C14ff19NOS: C, 67.43; H, 7.68. Found: 
3, 7-Dibenzyl-9,9-dimethoxy-3, 7-diazabicyclo[3.3. l]no- 45 
H d hi (12) 
C, 67.61; H, 7.73. 
nane y roperc orate 
EXAMPLE XXXV 
7-Benzyl-3-thia-7-azabicyclo[3.3. l]nonane 3-Oxide 
Hydroperchlorate (10) 
Caution: The use of shields, protective goggles and 
gloves is very strongly recommended when performing 
this reaction. The formation of explosive methyl per-
chlorate is a likely side reaction in this experiment. No 50 
difficulty was noted when the experiment was per- A 50-mL Erlenmeyer flask was equipped with a mag-
formed as described, but this may have been fortuitous. netic stirrer and an ice bath. To a stirred, chilled (5° C.) 
A one-necked, 100-mL, round-bottomed flask was solution of the sulfoxide (49, 0.47 g, 1.88 mmol) in ether 
equipped with a Soxhlet containing 3A molecular sieve (20 mL) and isopropyl alcohol (3 mL) was added drop-
(30 g), a condenser with a Ni inlet, a magnetic stirrer, 55 wise a solution of HC]O4 (60%, 0.63 g, 3.75 mmol) in 
and a heating mantle. The effective cycling volume of isopropyl alcohol (3 mL) over 30 min. Filtering of the 
the Soxhlet was approximately 20 mL. The flask was precipitate followed, and l~tter was washed with :ther 
charged with a solution of the ketone (19, 1.0 g, 3.12 (50 mL) and then recrystallized (95% ethanol) to give a 
mmol) in CH3OH (25 mL) and benzene (25 mL) to crystalline salt (10) (0.51 g, 78.1%); mp 137°-138° C. IR 
which was added HCIO4(60%, 1.5 g, 8.96 mmol) in one 60 (KBr) cm- 1 3090, 2970, 2950, 1465, 1095, 745, 705; 1H 
portion. The apparatus was flushed with N2 and the NMR (D3COD) 61.70 [bd, 1 H, H(9), J = 14.0 Hz], 2.01 
colorless solution was heated to reflux with cycling [bd, 1 H, H(9), J = 13.9 Hz], 2.61 [bd, 2 H, H(2,4)ax, 
through the Soxhlet. After 24 h, the now pale yellow J = 11.8 Hz], 2.69 [bs, 2 H, H(l,5)], 3.06 [bd, 2 H, 
solution was cooled to RT and concentrated to a white H(2,4)eq, J = 11.8 Hz], 3.36 [bd, 2 H, H(6,8)ax, J = 13.1 
solid which was filtered, washed with C6H6 (10 mL), 65 Hz], 3.94 (s, 2 H, ArCH2), 4.19 [bd, 2 H, H(6,8),q, 
and recrystallized (CH3OH, 80 mL) to afford the mono- J = 12.9 Hz], 7.35-7.42 (m, 5 H, Ar-H); 13C NMR 
perchlorate (0.91 g) as small white crystals, mp (D3COD) ppm 30.80 [C(9)], 36.27 [C(l,5)], 53.94 




131.49, 135.29; 15N NMR (DMSO-d6) ppm 56.45 [N(7)]. 
Anal. Calcd. for C14H20ClNSOs: C, 48.06; H, 5.76. 
Found: C, 47.84; H, 5.74. 
portion in a 50-mL, jacketed flask equipped with a mag-
netic stirrer, a condenser, a lower take-off condenser 
and two glass stoppers. A heating temperature of 
140'-150° C. for 4 h was produced by boiling o-xylene EXAMPLE XXXVI 
7-Benzyl-3-thia-7-azabicyclo[3.3.1 ]nonan-9-one 
6,8,10-14C3 (18)* 
5 (hp 144' C.) in the jacket. After cooling to RT, the 
solution was diluted with chilled H2O (30 mL) and 
extracted with ether (4X20 mL). Combined extracts 
were dried (Na2SO4, overnight) and filtered. Cooling of Caution: Special precautions should be taken when 
handling radioactive chemicals. All reactions should be 
carried out in a well ventilated hood with protective 10 
shields to prevent possible contamination of the lab 
area. Protective safety goggles as well as quality rubber 
gloves should also be worn at all times since exposure to 
the 14C materials could be dangerous. A 50-mL, three-
necked, round-bottomed flask was equipped with a 15 
magnetic stirrer, a heating mantle, a condenser with a 
N2 inlet, and two glass stoppers. To a mixture contain-
ing benzylamine (0.43 g, 4 mmol), [14C] benzylamine 
HCI [l mg, 7 X 10-3 mmol, 0.5 mCi (minimum activity, 
ICN)] in H2O (2.5 mL), and deoxygenated methanol (15 20 
mL) was added HCI (37%, 0.1 g, 1 mmol) followed by 
glacial acetic acid (0.36 g, 6 mmol). Addition in one 
portion of paraformaldehyde (0.96 g, 32 mmol) and 
[14C] paraformaldehyde [I mg, 3.3 X 10-2 mmol, 0.5 
mCi (minimum activity, ICN)] was followed by subse- 25 
quent addition of 4-thianone (43, 0.47 g, 4 mmol) all at 
once with stirring. After the mixture was heated at 
reflux under N2 for 6 h, the solution was concentrated to 
2-3 mL and then diluted with H2O (30 mL). The aque-
ous solution was extracted with ether (2X30 mL), and 30 
the latter was discarded. Chilling (via ice water bath) of 
the aqueous layer to below 5° C. was followed by basifi-
cation (pH~ 12) with Na OH pellets (97%, 0.29 g, 7 
mmol) which resulted in the formation of a cloudy 
suspension. Combined extracts (ether, 4 X 30 mL) were 35 
dried (Na2SO4, overnight), filtered, and concentrated 
(rotary evaporator) to give a viscous oil, which was 
then digested in 200 mL of Skelly B (hp 60° -68° C.) for 
0.5 h. Concentration of the supernatant afforded a yel-
low oil which was subjected to heating at high vacuum 40 
(110° C./0.1 mm Hg) in a sublimation apparatus to give 
0.13 g of ketone (18)*; mp 91°-93° C. The residue which 
remained was again dissolved in ether ( ~ 50 mL), and 
the latter solution was dried (Na2SO4, overnight), fil-
tered, and concentrated to an oil. Digestion of the oil 45 
was effected in 50 mL of Skelly B for 0.5 h, and the 
supernatant was concentrated to a viscous oil. This 
material was heated under vacuum (110° C./0.1 mm 
Hg) in a sublimation apparatus and gave 0.05 g of 
slightly crude ketone (18)*; mp 78° -80° C. A mixture 50 
melting point determination with the first crop was 
86° -88° C. without significant depression. This gave a 
total yield of0.18 g (17.7%) of ketone (18)* which was 
used without further purification in the next step. 
the ethereal solution to below 5° C. was followed by the 
dropwise addition of HClO4 (60%, I mL) over 10 min 
with stirring, which resulted in the formation of a white 
precipitate. Crude salt ( 48)* was filtered, recrystallized 
(95% EtOH), and dried over P20s (78° C./0.1 mm Hg) 
to give 0.14 g (58.6%) of white crystals of salt (48)*; mp 
154.5°-155.0° C.; (lit 155°-156' C.). A stock solution 
(3.49 mg/mL) of salt (48)* was prepared using DMSO, 
H2O, and O. lN HCl (40:53.5:6.5 by volume). Samples 
were made by diluting 4 µL of the stock solution with 
10 mL of Aquasol 2 scintillation cocktail (New England 
Nuclear Research Products). Measurements of activity 
were obtained at room temperature using a TRI-CARB 
liquid scintillation analyzer, model 1900 CA (Packard 
Instrument Company). An average count of 19,800 
DPM was observed for each sample and the specific 
activity was determined to be 0.64 µCi/mg. In similar 
fashion, samples were prepared from stock solution of 
the salt (48)* in methanol and the specific activity was 
determined to be 0.63 µCi/mg. 
To illustrate the useful biological properties of the 
compounds described in this invention, selected deriva-
tives were screened for antiarrhythmic activity using 
dog models. The clinically used agent lidocaine and 
7-benzyl-3-thia-7-azabicyclo[3.3. l]nonane hydroper-
chlorate (48) [U.S. Pat. No. 4,581,361] were employed 
as standards as basis for comparison. A small infarction 
was created in an area of the dog heart and thereafter 
electrical pacing was initiated to generate a sustained 
ventricular tachycardia (VT). This irregular beating 
pattern of the heart results in a reduction of the pump-
ing capability of the heart in a manner now accepted as 
resembling symptoms observed in humans during a 
heart attack (see: Scherlag, B. J. et. al., Am. J. Cardiol. 
1983, 51, 207; Bailey, B. R. et. al., J. Med. Chem. 1984, 
27, 759; Thompson, M. D. et. al., J. Med. Chem. 1987, 
30, 780; U.S. Pat. No. 4,581,361; and U.S. Pat. No. 
4,778,892 for further details, said references incorpo-
rated herein for such purposes). The effects of the se-
lected compounds in terms of ability to reduce the rate 
of the induced VT or to eliminate the same (abolish the 
VT completely or at least not allow it to be sustained) is 
then evaluated and compared to lidocaine or to 7-ben-
zyl-3-thia-7-azabicyclo[3.3. l]nonane hydroperchlorate 
(48). Since the latter hydroperchlorate proved superior 
EXAMPLE XXXVII 
7-Benzyl-3-thia-7-azabicyclo[3.3. l]nonane 
Hydroperchlorate 6,8,10-14C3 (48)* 
55 to lidocaine in most of the studies, data in Table A are 
compared to that obtained for the salt (48) cited herein. 
In Table A, it is clear that salts (1), (3), (5), (11), (13), 
and (14) are extremely effective in eliminating the in-
Caution: Special precautions should be taken when 
handling radioactive chemicals. All reactions should be 60 
carried out in a well ventilated hood with protective 
shields to prevent possible contamination of the lab 
area. Protective safety goggles as well as quality rubber 
gloves should also be worn at all times since exposure to 
the 14C materials could be dangerous. To a mixture of 65 
KOH pellets (85%, 0.48 g, 8.5 mmol) and the ketone 
(18)* (0.18 g, 0.71 mmol) in triethylene glycol (5 mL) 
was added hydrazine (95%, 0.23 g, 7.1 mmol) in one 
duced VT as was the standard 7-benzyl-3-thia-7-
azabicyclo[3.3.l]nonane hydroperchlorate (48) at 3 
mg/kg as well as at 6 mg/kg. Salts (10), (12), (15), and 
(17) reduced the rates of the induced VT but did not 
abolish them. In contrast, salt (8) exhibited little effect 
on the dog model which suggests there exists a high 
degree of specificity of action of these molecules in 
terms of antiarrhythmic activity. Thus, these heterocy-
clic molecules claimed in this application have elec-




Radioactivity-time data obtained by analysis of blood 
samples collected after intracardiac or oral administra-
tion are recorded in Tables B and C so designated. 
Coefficients and exponents of the disposition curves 
the standard 7-benzyl-3-thia-7-azabicyclo[3.3. l]nonane 
hydroperchlorate (48) which is known to have such 
superior properties to those of lidocaine (see: U.S. Pat. 
No. 4,581,361 and U.S. Pat. No. 4,778,891) which is a 
clinically used agent for the treatment of victims of 
heart attacks. 
In principle, it is felt that the compositions of the 
present invention can be employed separately or incom-
bination with each other or in combination with other 
drugs to achieve either individually or in combination 
the desired antiarrhythmic properties. It is expected 
that the composition can be utilized and administered 
via a variety of methods including by way of an exam-
ple, but not limited thereto, intravenously, orally, by 
suppository, by inhalation, and the like. Furthermore, it 
is generally felt that the compositions as claimed either 
specifically possess antiarrhythmic activity or generally 
are broad biologically active or the respective composi-
tions are intermediates to antiarrhythmic and biologi-
cally active species that are released or created in situ as 
the result of administration of the drug. 
5 which best described changes in blood radioactivity 
with time after administration were obtained using a 
microcomputer program [R. D. Brown et al. J. Pharma-
ceutical Sciences, 67, 1687 (1978)]. The disposition of 
(48)* after intacardiac administration was well de-
TABLE A 
ANTIARRHYTHMIC PROPERTIES 
10 scribed by a two-compartment open model and the 
pharmacokinetic parameters derived from the analysis 
of individual blood radioactivity data are presented in 
Table D so designated. The median half-life of elimina-
tion <THm) of radioactivity was 5.7 hours, which sug-
15 gested that a moderate to reasonably long dosage inter-
val might be appropriate for therapeutic use. The me-
dian apparent volume of distribution, based on total 
area under the disposition curve (V d(area)), was high 
(4070 ml/kg) indicating extensive distribution into body 
20 tissues. The high total body clearance value (Cls=470) 
confirms the presence of efficient drug elmination path-
OF REPRESENTATIVE 3-AZABICYCL0[3.3. l]NONANE SAL TS 
6 5 4 
I \ \ 
y 92 N-R HX 
\ I I Q 
2 
(Effect on SVTb) 
Comp0 R y z 3 mg/kg 6 mg/kg 
(1) CH(CH3)2 NC(O)Ph CH2 NSVT NSVT 
(3) CH(CH3)2 NCH2C6~·3,4(0CH3)2 CH2 NSVT NSVT 
(5) CH(CH3)2 NCH2Ph CH2 NSVT NSVT 
(8) CH(CH3)2 s CH2 No action No action 
(Stand.-48) CH2Ph s CH2 NSVT' NSVT 
(10) CH2Ph s• o CH2 Reduced Reduced 
rate of VT rate of VT 
(11) CH2Ph s C(OCH3)2 NSVT NSVT 
(12) CH2Ph NCH2Ph C(OCH3)2 Reduced Reduced 
rate of VT rate of VT 
(13) CH2Ph CHC02Et CH2 NSVT NSVT 
(14) CH2Ph CHC02Et C(SCH2h NSVT NSVT 
(15) NC(O)Ph s CH2 Reduced Reduced 
rate of VT rate of VT 
01l CH2Ph NCH2Ph CH2 Reduced Reduced 
rate of VT rate of VT 
"X = CIO4, Cl, Br, citrate, fumarate, HSO4 
"sVT = Sustained ventricular tachycardia induced by electric! pacing of infarctw dog heart 
'NSVT = Nonsustained ventricular tachycardia (or abolished ventricular tachycardia) 
dAII compounds have Q is CH2 except (17) where Q is c=o 
In order to determine the potential viability of mem- 55 
bers of the above family to act as useful antiarrhythmic 
agents in vivo, a pharmacokinetic and metabolism study 
was undertaken using a representative example from the 
above compounds, The techniques employed in these 
preliminary studies are well documented, but a sum- 60 
mary ofpharmacokinetic procedures can be found in: J. 
D. Baggot, "Principals of Drug Disposition in Domes-
tic Animals: The Basis of Veterinary Clinical Pharma-
cology", W. B. Saunders Company, Philadelphia, 1977. 
These studies were conducted using 14C-labelled (48)* 65 
[Prepared by the method of Zisman, Berlin, et al. J. 
Labelled Compounds and Radiopharmaceuticals, In 
Press (1989)] in Sprague-Dawley rats. 
ways. 
Pharmacokinetic terms describing changes in blood 
radioactivity after oral administration are presented in 
Table D so designated. Compartmental analysis showed 
that the data fitted a one-compartment pharmacokinetic 
model. Oral dosing resulted in rapid and extensive ab-
sorption and peak concentrations within 30 minutes 
after administration. The ratio of the areas under the 
radioactivity-time curves obtained after oral and intra-
cardiac administration (AUCpo/ AUC;c) indicates a high 
bioavailability (±81 % ). Thus, the oral route of adminis-
tration may be suitable for therapeutic management of 





Kinetics of appearance of radioactivity 
(dpm/ml] in blood after intracardiac 
administration of a bolus dosage (IO mg/kg) 
of (48)" (1332000 dem/mg). 
Time after 
administration Individual rats 
(hours) #2 #3 #8 #9 #10 #15 #16 Mean SD 
0.0333 6802 6732 6419 6173 6595 7140 6644 333 
0.0833 5482 5424 5496 5661 6106 7262 5905 710 
0.1667 4741 5520 6087 4903 4780 5752 6435 5460 674 
0.3333 4807 4225 4261 4768 5219 6197 4913 731 
0.5 5294 3233 4210 4228 5152 3938 4343 773 
1 2911 3619 4182 4343 3002 3433 3873 3623 551 
2 1862 2004 2495 2451 2721 2463 1907 2272 340 
3 1307 2357 2369 2314 2087 520 
4 1374 1382 2316 2429 2379 1578 1438 1842 504 
6 1719 2089 1905 2186 1690 1377 1828 295 
10 1005 1113 1123 1191 903 1040 900 1039 112 
16 534 332 515 353 395 349 413 89 
24 242 308 71 60 178 197 144 171 89 
TABLEC Table E so designated. High levels of radioactivity 
Kinetics of appearance of radioactivity [dpm/ml] 
were measured in liver and kidney which is consistent 
with the extensive metabolism and excretion of metabo-
in blood after oral administration of 
lites commonly encountered with highly lipid soluble a bolus dosage (10 mg/kg) of (48)* (1332000 dem/mg). 
Time after 25 xenobiotics [agent (48)* has both polar and nonpolar 
admini- structural features]. These observations correlate well 
stration Individual rats with the high volume of distribution calculated from 
(hours) #4 #6 #7 #11 #12 #13 Mean SD pharmacokinetic data. Reasonably high concentrations 
0.1667 1928 802 1026 1601 479 967 1134 534 of radioactivity in the heart confirm that ( 48)* achieves 
0.3333 2153 1723 2311 3265 754 1946 2025 818 good penetration into the target organ. Radioactivity in 
0.5 4281 2086 2659 4421 1025 2151 2771 1335 30 the brain and perirenal fat were low in comparison with 
1 3895 1911 2272 3154 958 2106 2383 1022 
2 2208 1545 1618 2896 991 2043 1884 654 other tissues and decreased steadily with time after 
4 1786 2034 2114 2017 1767 1713 1905 169 administration. This suggests that central neurotoxicity 
6 1601 1502 1224 1594 1714 1138 1462 230 may not limit the therapeutic use of these agents and 
10 893 662 885 1118 1613 984 1026 324 that Jong-term accumulation in fat depots may not pres-
16 418 245 302 140 586 390 347 154 35 
24 300 89 79 66 197 75 134 95 ent a toxicological hazard. 
Thin layer chromatographic analysis of urine samples 
collected after oral administration of 14C-labelled (48)* 
TABLED 
Pharmacokinetic values derived from each rat's (48)* blood disposition curves. 
I. Intracardiac administration: 
Individual rats 
Determinant 2 3 8 9 10 15 16 Mean SD 
A (dpm/ml) 3670 3924 2583 2532 2350 3852 5097 3330 966 
B (dpm/ml) 2192 2152 4333 4647 3659 2972. 2652 
a (hr- 1) 1.36 0.86 1.93 11.49 2.18 1.48 1.62 
1616 1808 
1.55 2.96 
fJ (hr- 1) 0.090 0.080 0.163 0.164 0.131 0.115 0.121 0.124 0.035 
K21 (hr- 1) 0.568 0.359 1.276 7.499 1.380 0.710 0.636 1.775 2.551 
K,i(hr- 1/ 0.217 0.194 0.248 0.252 0.207 0.241 0.310 
K12 (hr-) 0.673 0.394 0.578 3.908 0.726 0.646 0.800 
0.238 0.038 
1.103 1.243 
lj(,6) (hr) 7.67 8.60 4.23 4.20 5.28 5.99 5.70* 
lj(a) (hr) 0.50 0.79 0.35 0.06 0.31 0.46 0.42* 
C 0 (dpm/ml) 5863 6077 6917 7179 6010 6824 7750 6660 701 
V,(ml/kg) 2271 2191 1925 1855 2216 1951* 1718 
V d!_arta) (ml/kg) 5471 5291 2926 2843 3504 4070* 4390 
V .«_ss) (ml/kg) 4963 4596 2798 2822 3381 3725* 3879 
Cls (ml/hr , kg) 494 426 478 468 459 470* 533 
AUC;c 25282 27480 29169 30489 28444 27126 24104 27442 2205 
I. Oral administration: 
Individual rats 
Determinant 4 6 7 II 12 13 Mean SD 
fJ (hr- 1) 0.107 0.138 0.143 0.181 0.149 0.137 0.143 0.023 
lj(,6) (hr) 6.42 5.00 4.81 3.80 4.63 5.04 4.90* 
AUCpo 25306 18755 20243 24510 24383 20555 22292 2760 
AUCpclAUC;, 0.81233 
•values represent medians 
Tissue distribution of (48)* was studied by measuring 65 
the radioactivity in selected organs collected from rats 
sacrificed at several time intervals after oral administra-
tion. Data obtained from these studies is reported in 
to rats indicated that most of the dose was excreted in 




major metabolite was identified as 14C-labelled (15)*, 
the structure of which was confirmed by comparison 
with an authenticated sample of unlabelled (15). Conse-
quently, amide (15) is an active metabolite of (48) and is 
therefore a potentially viable agent in its own right. 
TABLEE 
Concentration of radioactivity in selected organs 
and tissues after oral administration of a 








































II III Mean 
I. Blood concentrations (dpm/ml): 
2330 1970 3975 2758 
5170 6755 4615 5513 
6020 6010 4935 5655 
4370 3335 4245 3983 
2840 2790 3300 2977 
2060 2580 1800 2147 
740 650 740 710 
276 219 295 263 
I. Kidney concentrations (dpm/g): 
11320 5425 21341 12695 
27222 34142 20528 27297 
31622 39516 28700 33279 
26793 19249 24987 23676 
18881 16254 21566 18900 
15219 17715 12217 15050 
4963 4835 5296 5031 
2591 1761 2285 2212 
1250 2489 1004 1581 
I. Liver concentrations (dpm/g): 
49025 37302 33768 40032 
774 79 86705 53662 72615 
82327 81324 68846 77499 
40648 16117 46449 34405 
14156 18970 21791 18306 
14430 17811 15814 16018 
10272 9195 9855 9774 
6886 4065 4948 5300 
3427. 4709 2563 3566 
I. Heart concentrations (dpm/g): 
4813 1236 4292 3447 
5402 5647 3890 4980 
5071 4903 4107 4694 
3442 2785 3608 3278 
2415 2511 2736 2554 
1820 2114 1676 1870 
826 668 790 761 
336 273 412 340 
221 320 184 242 



















2583 647 4670 2633 
16771 1925 926 6541 
1606 2068 2145 1940 
1070 1866 2599 1845 
718 933 745 799 
610 508 562 560 
577 172 558 436 
216 138 271 208 
77 119 97 98 
I. Brain concentrations (dpm/g): 
1280 296 1496 1024 
1562 1980 1028 1523 
824 971 643 813 
711 1051 551 771 
477 506 626 536 
399 343 399 380 
248 232 274 251 
108 106 92 102 























































the broader definition of such terms used in the prior art 
and the more specific use of the terms herein, the more 
specific meaning is meant. 
While the invention has been described with a certain 
5 degree of particularity it is manifest that many changes 
may be made in the details of construction and the ar-
rangement of components without departing from the 
spirit and scope of this disclosure. It is understood that 
the invention is not limited to the embodiments set forth 
10 herein for purposes of exemplification, but is to be lim-
ited only by the scope of the attached claim or claims, 
including the full range of equivalency to which each 
element thereof is entitled. 
15 
20 
What is claimed is: 
1. A 3-azabicyclo[3.3.l]nonane compound having the 
formula: 
I \ \ 
where X is ClO4, Br, Cl, HSO4, citrate or fumarate and 
25 
where Y is PhC(O)N, 4-CIC6~C(O)N, 3,4-
(H3CO)2C6H3C(O)N, 3,4,5-(H3CO)3C6H2C(O)N, 




2. A 3-azabicyclo[3.3.l]nonane compound having the 
formula: 
I \ \ 
Y Z N-PhCH2 HX 
\.___._I_ iH2 
where X is CIO.i, Br, Cl, HSO4, citrate or furmarate, 
40 where Y is S, S--0, or C2H5O(O)C and where Z is 







3. A 3-azabicyclo[3.3.l]nonane compound having the 
formula: 
I \ \ 
S CH2 N-R HX 
\'-_ ... !_ iH2 
where Xis CIO4, Br, Cl, HSO4, citrate or fumarate, and 
where R is 3-I-C6~CH2 or PhC(O). 
4. A 3-azabicyclo[3.3.l]nonane compound having the 
60 formula: 
The claims and the specification describe the inven-
tion presented and the terms that are employed in the 
claims draw their meaning from the use of such terms in 65 
the specification. The same terms employed in the prior 
art may be broader in meaning than specifically em-
ployed herein. Whenever there is a question between 
I \ \ 
CH2 N-PhCH2 HX 
\.___._I_ iH2 
where X is CIO4, Br, Cl, HSO4, citrate or fumarate. 
33 
5,084,572 
5. A 3-azabicyclo[3.3. l]nonan-9-ones compound hav-
ing the formula: 
where Y is CHC02Et or NCH(CH3)2. 
6. A 3-azabicyclo[3.3.l]nonan-9-ones compound hav-





/ \ \ 
S CH2 N-R 
\ I I 
where R is H or C(O)Ph. 
9. A 3-azabicyclo[3.3.l]nonane compound having the 
formula: 
/ \ \ 
(CH3)2CHN CH2 N-R 
\ I I 
where R is CH2Ph,H,C(O)Ph, C(O)-C6li4-4-CI, 
C(O)C6fl3-3.4-(0CH3)2, C(O)C6ll2-3,4,5-(0CH3)2, or 
S(0)2Ph. (CHal,CHN ~N-R 
20 10. A 3-azabicyclo[3.3. l]nonane compound having 
where R is CH2C6li4-4-Cl, CH2C6H3-3,4-(0CH3)2; or 
CH2C6H2-3,4,5-(0CH3)3. 
7. A 3-azabicyclo[3.3. l]nonan-9-ones compound hav- 25 
ing the formula: 
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